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A B S T R A C T
Background
This is an update of the Cochrane review ‘Memory rehabilitation for people with multiple sclerosis’ (first published in the Cochrane
Library 14March 2012, Issue 3). Impairments in cognitive function, particularly memory, are common in people with multiple sclerosis
(MS) and can potentially affect their ability to complete functional activities. There is evidence from single-case or small group studies
that memory rehabilitation can be beneficial for people with MS, but findings from randomised controlled trials (RCTs) and systematic
reviews have been inconclusive.
Objectives
To determine whether people with MS who received memory rehabilitation showed: 1. better outcomes in their memory functions
compared to those given no treatment or receiving a placebo control; and 2. better functional abilities, in terms of activities of daily
living, mood, and quality of life, than those who received no treatment or a placebo.
Search methods
We searched the Trials Specialised Register of the Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group (2 June 2015) and
the following electronic databases: The NIHR Clinical Research Network Portfolio database (NIHR CRN) (from 2010 to June 2015),
The Allied and Complementary Medicine Database (AMED) (2010 to June 2015), British Nursing Index (BNI) (2010 to June 2015),
PsycINFO (2011 to June 2015), and CAB Abstracts (2010 to June 2015). Start dates for the electronic databases coincided with the
last search for the previous review. We handsearched relevant journals and reference lists.
Selection criteria
We selectedRCTs or quasi-randomised trials ofmemory rehabilitation or cognitive rehabilitation for people withMS inwhich amemory
rehabilitation treatment group was compared to a control group. Selection was conducted independently first and then confirmed
through group discussion. We excluded studies that included participants whose memory deficits were the result of conditions other
than MS unless we could identify a subgroup of participants with MS with separate results.
Data collection and analysis
Three review authors were involved in this update in terms of study selection, quality assessment, and data extraction. We contacted
investigators of primary studies for further information where required. We conducted data analysis and synthesis in accordance with
the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). We performed a ’best evidence’ synthesis based on the
methodological quality of the primary studies included.
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Main results
Weadded seven studies during this update, bringing the total to 15 studies, involving 989participants. The interventions involved various
memory retraining techniques, such as computerised programmes and training on internal and external memory aids. Control groups
varied in format from assessment-only groups, discussion and games, non-specific cognitive retraining, and attention or visuospatial
training. The risk of bias of the included studies was generally low, but we found eight studies to have high risk of bias related to certain
aspects of their methodology.
We found significant effect of intervention on objective assessments of memory in both the immediate and long-term follow-ups:
standardised mean difference (SMD) 0.23 (95% confidence interval (CI) 0.05 to 0.41) and SMD 0.26 (95% CI 0.03 to 0.49),
respectively. We also found significant effect of intervention for quality of life in the immediate follow-up (SMD 0.23 (95% CI 0.05
to 0.41)). These findings showed that the intervention group performed significantly better than the control group. We also found a
significant difference for activities of daily living (ADL) in the long-term follow-up (SMD -0.33 (95% CI -0.63 to -0.03)), showing
that the control groups had significantly less difficulty completing ADLs than the intervention groups. We found no significant effects,
either immediate or long-term, on subjective reports of memory problems (SMD 0.04 (95% CI -0.19 to 0.27) and SMD 0.04 (95%
CI -0.19 to 0.27)); on mood (SMD 0.02 (95% CI -0.16 to 0.20) and SMD -0.01 (95% CI -0.21 to 0.20)); and on immediate follow-
up for ADL (SMD -0.13 (95% CI -0.60 to 0.33)) and in the long term for quality of life (SMD 0.16 (95% CI -0.03 to 0.36)). We
could not complete a sensitivity analysis of intention-to-treat in comparison with per-protocol analysis, due to insufficient information
from the included papers. However, a sensitivity analysis of high- versus low-risk studies suggested that while quality of the trials did
not affect most outcomes, differences were seen in the objective memory outcomes (both at immediate and long term) and quality of
life (immediate) outcome, with studies with higher risk of bias inflating the overall effect size estimates for these outcomes, and the
test of overall effect changing from being statistically significant to not significant when studies at high risk of bias were excluded. This
suggests that lower-quality studies may have positively influenced the outcomes.
Authors’ conclusions
There is some evidence to support the effectiveness of memory rehabilitation on memory function, as well as on quality of life. However,
the evidence is limited and does not extend to subjective reports of memory functioning or mood. Furthermore, the objective measures
used are not ecologically valid measures, and thus potentially limit generalisability of these findings into daily life. Further robust RCTs
of high methodological quality and better quality of reporting, using ecologically valid outcome assessments, are still needed.
P L A I N L A N G U A G E S U M M A R Y
Memory rehabilitation in multiple sclerosis
Review question
Do people with MS who received memory rehabilitation show: 1. better outcomes in their memory functions compared to those given
no treatment or receiving a placebo control; and 2. better functional abilities, in terms of activities of daily living, mood, and quality
of life, than those who received no treatment or a placebo.
Background
People with multiple sclerosis (MS) often struggle with memory problems, which can lead to difficulties in everyday life. Memory
rehabilitation is offered to help enhance the ability to perform everyday activities and to increase independence by reducing forgetting.
Such rehabilitation can involve the use of specific techniques and strategies to change the way a person tries to remember, store, or
retrieve memories. However, it is unclear whether memory rehabilitation is effective in reducing forgetting or improving performance
of activities of daily living. Currently there are few good-quality studies that have investigated the effectiveness of memory rehabilitation
in people with MS.
Study characteristics
This review included 15 studies with 989 participants involving various types of memory retraining techniques, some using computer
programs or memory aids such as diaries or calendars.
Key results and quality of the evidence
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The results of this review showed some evidence to support the use of memory rehabilitation in people with MS. Those participants
who had memory rehabilitation had better memory functioning compared to those who did not receive memory rehabilitation, and
this difference between groups was found after the intervention was completed and for some time thereafter. However, this outcome
was usually measured on assessments that were abstract and did not reflect people’s daily life. Those participants who received memory
rehabilitation also showed better quality of life, but this effect was not maintained long term. We also found that those participants
who did not receive the memory rehabilitation were better at completing activities of daily living, but these differences between groups
were small. The groups who did and did not receive memory rehabilitation did not differ in terms of their subjective reports of memory
problems or mood. There are still relatively few large, good-quality studies to base our findings on, so more are needed.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Memory rehabilitation for people with multiple sclerosis
Patient or population: people with multiple sclerosis
Settings:
Intervention: memory rehabilitation
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of Participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Control Memory rehabilitation
Subjective memory
measures - immediate
EMQ, MSNQ, MFQa
Follow-up: median 1.5 to
5 months
- The mean subjective
memory measures - im-
mediate in the interven-
tion groups was
0.04 standard deviations
higher
(0.19 lower to 0.27
higher)
- 314
(5 studies)
⊕⊕⊕©
moderateb
SMD 0.04 (-0.19 to 0.27)
Subjective memory
measures - long term
EMQ, MSNQ, MFQa
Follow-up: 3 to 8 months
- The mean subjective
memory measures - long
term in the intervention
groups was
0.04 standard deviations
higher
(0.19 lower to 0.27
higher)
- 305
(5 studies)
⊕⊕⊕©
moderateb
SMD 0.04 (-0.19 to 0.27)
Objective memory mea-
sures - immediate
RBMT,CVLT,
AVLT, HVLT, VLT, LNNB,
BRBNT, MUSICa
- Themean objectivemem-
ory measures - imme-
diate in the intervention
groups was
0.23 standard deviations
- 503
(11 studies)
⊕©©©
very lowb,c,d
SMD 0.23 (0.05 to 0.41)
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Follow-up: 1 to 5 months higher
(0.05 to 0.41 higher)
Objective memory mea-
sures - long term
RBMT, CVLT, AVLT,
HVLT, VLT, BRBNT, MU-
SICa
Follow-up: 3 to 8 months
- Themean objectivemem-
ory measures - long term
in the intervention groups
was
0.26 standard deviations
higher
(0.03 to 0.49 higher)
- 302
(6 studies)
⊕⊕©©
lowb,e
SMD 0.26 (0.03 to 0.49)
Mood - immediate
GHQ, BDI, BDI-FS,
Chicago Multiscale De-
pression Inventorya
Follow-up: 1-5 months
- The mean mood - imme-
diate in the intervention
groups was
0.02 standard deviations
higher
(0.16 lower to 0.20
higher)
- 490
(9 studies)
⊕⊕©©
lowb,f
SMD 0.02 (-0.16 to 0.20)
Mood - long term
GHQ, BDI, BDI-FS,
Chicago Multiscale De-
pression Inventorya
Follow-up: 3 to 8 months
- The mean mood - long
term in the intervention
groups was
0.01 standard deviations
lower
(0.21 lower to 0.20
higher)
- 413
(7 studies)
⊕⊕©©
lowb,g
SMD -0.01 (-0.21 to 0.
20)
Acitivities of daily living
- immediate
EADLa
Follow-up: 4 to 5 months
- The mean activities of
daily living - immediate
in the intervention groups
was
0.13 standard deviations
lower
(0.6 lower to 0.33 higher)
- 186
(2 studies)
⊕⊕⊕⊕
high
SMD -0.13 (-0.6 to 0.33)
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Activities of daily living -
long term
EADLa
Follow-up: 7 to 8 months
- The mean activities of
daily living - long term
in the intervention groups
was
0.33 standard deviations
lower
(0.63 to 0.03 lower)
- 186
(2 studies)
⊕⊕⊕⊕
high
SMD -0.33 (-0.63 to -0.
03)
Quality of life - immedi-
ate
MSIS, FAMS, MSQOL,
SF-36, SF-12a
Follow-up: 1.5 to 4
months
- The mean quality of life -
immediate in the interven-
tion groups was
0.23 standard deviations
higher
(0.05 to 0.41 higher)
- 485
(7 studies)
⊕⊕⊕©
moderateb
SMD 0.23 (0.05 to 0.41)
Quality of life - long term
MSIS, FAMS, MSQOL SF-
36, SF-12a
Follow-up: 4 to 8 months
- The mean quality of life -
long term in the interven-
tion groups was
0.16 standard deviations
higher
(0.03 lower to 0.36
higher)
- 406
(5 studies)
⊕⊕⊕©
moderateb
SMD 0.16 (-0.03 to 0.36)
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the
assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CI: confidence interval; SMD: standardised mean difference
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
aEMQ: Everyday Memory Questionnaire, MSNQ: Multiple Sclerosis Neuropsychological Screening Questionnaire, MFQ: Memory
Functioning Questionnaire, RBMT: Rivermead Behavioural Memory Test, CVLT: California Verbal Learning Test, AVLT: Auditory Verbal
Learning Test, HVLT: Hopkins Verbal Learning Test, VLT: Verbal Learning Test, LNNB: Luria-Nebraska Neuropsychological Battery,
BRBNT: Brief Repeatable Battery of Neuropsychological Tests, GHQ: General Health Questionnaire, BDI: Beck Depression Inventory,
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BDI-FS: Beck Depression Inventory-Fast Screen, EADL: Extended Activities of Daily Living, MSIS: Multiple Sclerosis Impact Scale,
FAMS: Functional Assessment of Multiple Sclerosis, MSQOL: Multiple Sclerosis Quality of Life, SF-36: 36-Item Short Form Health
Survey, SF-12: 12-Item Short Form Health Survey
bDowngraded by 1 due to 95% confidence intervals including no effect, and the upper or lower confidence intervals limit crosses an
effect size of 0.5 in either direction.
c4 of 11 studies had possible risk of bias related to random sequence generation, and in 2 of 11 studies this was unclear. Allocation
concealment was potentially biased in 1 study, and unclear in 5 of 11 studies. Blinding was a potential source of bias in 2 studies.
Incomplete outcome data may have biased 2 of 11 studies and was unclear in 4 of 11 studies.
d7 of 11 studies used a list-learning task as an objective measure of memory, which has poor ecological validity.
e4 of 6 studies used a list-learning task as an outcome measure for objective memory, which has poor ecological validity.
f 2 of the 9 studies showed potential risk of bias relating to random sequence generation, and for 1 study this was unknown. 1 study
had potential risk of allocation concealment bias; this was unclear for 2 studies. 1 study had potential risk of bias related to blinding. 2
studies had risk of bias due to incomplete outcome data, and this was unknown for 2 studies.
g1 of 7 studies showed potential risk of bias related to random sequence generation, and for 1 this was unclear. 1 study showed potential
risk of bias related to allocation concealment. 1 study showed potential risk of bias related to blinding, and 1 study showed potential risk
of bias related to incomplete outcome data; this was unknown for 2 studies.
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B A C K G R O U N D
Description of the condition
Multiple sclerosis (MS) is an inflammatory disease of the central
nervous system that causes physical or cognitive disturbances, or
both. The prevalence of these cognitive problems, which include
dysfunctions in memory, attention, speed of information process-
ing, and executive functions, varies from 43% to 72% (Prosiegel
1993). Rao 1993 reported that impaired memory functions were
evident in 40% to 60% of people with MS. Impairments in cog-
nitive functions are also related to low mood (Chiaravalloti 2008;
Gilchrist 1994), and have the potential to hamper functions re-
lated to activities of daily living (ADL) (Kalmar 2008; Langdon
1996).
Description of the intervention
Cognitive rehabilitation is a specialised facet of neuropsycholog-
ical rehabilitation that assists in the development of functional
independence and adjustment of individuals with brain damage
through targeted intervention or focused stimulation (Robertson
1993). Robertson 2008 defined cognitive rehabilitation as a “struc-
tured, planned experience derived from an understanding of brain
function which ameliorates dysfunctional cognitive and brain pro-
cesses caused by disease or injury and improves everyday life func-
tion”. Memory rehabilitation is a major component of the man-
agement of people with memory problems, and is either imple-
mented as part of a comprehensive cognitive rehabilitation pro-
gramme or as a stand-alone intervention, depending on the needs
and neuropsychological profile of the patient.
How the intervention might work
There is uncertainty about the precisemechanisms bywhichmem-
ory rehabilitation interventions work. However, it is widely be-
lieved that they provide people with the knowledge of and infor-
mation about their memory problems, by teaching them to use
internal and external memory aids, different strategies to pay at-
tention, and alternative ways of encoding, storing, and retrieving
information. Targeted, repeated stimulation of certain brain areas
using drill and practice cognitive exercises are thought to trigger
the activation of neural networks. For group-based interventions,
the therapeutic effects of being with others with similar problems
may also help. Some of these behavioural strategies (referred to as
’restitution’ or ’compensation’) are believed tomap onto the neural
networks engaged in performing memory functions.
Why it is important to do this review
Studies have examined the effectiveness of memory rehabilitation
using different methodologies. Single-case and small group stud-
ies have reported positive results of memory rehabilitation, but
the results obtained from randomised controlled trials (RCTs) and
some systematic reviews have been less positive and reported in-
conclusive evidence. Some reviews (for example Cicerone 2005;
Cicerone 2011) have concluded that there is compelling evidence
for memory strategy training with participants with mild memory
problems, that errorless learning may be effective for those with
severe memory impairments (albeit with limited generalisability
to new tasks or overall memory problems), and that the use of
external memory aids may be beneficial for people with moder-
ate to severe memory problems. Cicerone 2011 also suggest that
group-based interventions may be considered for remediation of
memory deficits. However, these reviews focused mainly on peo-
ple with traumatic brain injury. Cochrane reviews by Majid 2000
and das Nair 2007a found insufficient evidence to support or re-
fute the effectiveness of memory rehabilitation following stroke.
Some reviews have focused on generic psychological interventions
for people with MS (Thomas 2006), or neuropsychological in-
terventions for people with MS (Rosti-Otajärvi 2011), however
these were not specific to memory rehabilitation. The Thomas
2006 review did not consider grey literature and was unable to
draw any “definite conclusions”. The Rosti-Otajärvi 2011 review
focused on neuropsychological rehabilitation across a number of
cognitive domains, as well as associated health-related factors and
emotional well-being. This current systematic review is focused
solely on the effectiveness of memory rehabilitation for people
with MS; databases were searched that were not searched as part
of the Rosti-Otajärvi 2011 review, and studies are included that
were not in their review. This is an update of the Cochrane review
‘Memory rehabilitation for people with multiple sclerosis’ (first
published in the Cochrane Library 2012, Issue 3).
O B J E C T I V E S
The aims of this systematic review were to determine whether
people with MS who received memory rehabilitation showed:
1. Better outcomes in their memory functions compared to
those given no treatment or a placebo control; and
2. Better functional abilities, in terms of activities of daily
living, mood, and quality of life, than those who received no
treatment or a placebo.
M E T H O D S
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Criteria for considering studies for this review
Types of studies
We sought randomised and quasi-randomised controlled trials,
as defined by the Cochrane Handbook for Systematic Reviews of
Interventions (Higgins 2011), and the pre-cross-over component
of randomised cross-over trials with people with MS, in which a
memory treatment was compared to a control, for inclusion in the
review. Where papers were based on the same sample, or subset of
a larger sample, we included only the study with the full sample
so as to avoid double counting. If a study was available through
both grey literature (for example conference abstract) and a peer-
reviewed publication, we used the peer-reviewed publication in
the first instance.
Types of participants
Trials included in this review were limited to those with people
with MS (including relapsing remitting, secondary progressive,
and primary progressive). We thus excluded trials with partici-
pants whose memory deficits were the result of traumatic brain
injury, brain tumour, stroke, epilepsy, or any other neurological
condition, unless we could define a subgroup of people with MS
for which there was separate data. Included studies were to base
a diagnosis of MS on well-established diagnostic criteria, for ex-
ample Paty 1988 and Poser 1983 (and revised versions of the Mc-
Donald criteria (Polman 2005; Polman 2011)).We did not define
memory deficits in advance as we assumed that those people with
MS who were given treatment for impaired memory had memory
deficits. We placed no restrictions on the type of memory deficits
participants reported.
Types of interventions
We included trials in which there was a comparison between a
treatment group that received one of various memory rehabilita-
tion strategies, and a control group that received either a placebo
or no memory intervention. We considered rehabilitation to take
place over more than a single session; therefore, we did not con-
sider lab-based experiments (such as single-session list-recall or
mnemonic strategy training) as rehabilitation. Control groups
needed to have people with MS or a subgroup of people with MS
amongst those with other diagnoses, for whom separate data were
available. We considered memory treatments to be any attempt
to modify memory function by means of drill-and-practice, or by
the use of internal and/or external memory aids, or by teaching
people with MS strategies to cope with their memory problems.
We did not include drug studies.
Types of outcome measures
Primary outcomes
Primary outcomes were measures of the extent of memory prob-
lems in everyday life. There are several ways in which this is as-
sessed in clinical practice and research, but we only included mea-
sures that directly assessed this construct. If there was more than
one outcome measure measuring this construct in a study, we used
the following hierarchy of commonly used tests:
1. For subjective reports of memory: we considered Everyday
Memory Questionnaire (EMQ) (Sunderland 1983), over the
Cognitive Failures Questionnaire (Broadbent 1982), over the
Subjective Memory Questionnaire (Davis 1995), over the
Memory Assessment Clinics Questionnaire (Crook 1992).
2. For objective reports of memory: we considered Rivermead
Behavioural Memory Test (RBMT) (Wilson 1985 or newer
versions of this test), over Wechsler Memory Scale (WMS)
(Wechsler 1997 or newer versions of this test), over Cambridge
Test of Prospective Memory (Wilson 2005), over Doors and
People Test (Baddeley 1994).
We based these hierarchies on the tests’ degree of sensitivity to
assess everydaymemory problems. For objective assessmentswhere
the outcomes were not in the above hierarchy, we used general
memory test scores over verbal memory test scores over visual
memory test scores. If outcome measures were used that were not
in this hierarchy, we arrived at a consensus following discussion
regarding which measures to consider as the primary outcome
measure, before the statistical analyses were conducted, so as to
minimise bias.
Secondary outcomes
1. Mood, such as the General Health Questionnaire (GHQ)
(Goldberg 1988), Hospital Anxiety and Depression Scale
(HADS) (Zigmond 1983); Beck Depression Inventory-Fast
Screen (Beck 2003).
2. Functional abilities, such as the Functional Independence
Measure (FIM) (Uniform Data System for Medical Rehab 1993),
Functional Assessment Measure (FAM) (Hal 1997), Nottingham
Extended Activities of Daily Living (EADL) (Nouri 1987).
3. Quality of life, such as the Multiple Sclerosis Impact Scale
(MSIS) (Hobart 2001) World Health Organization Quality of
Life assessment (WHO-QoL) (The WHOQOL Group 1993),
36-item Short Form Health Survey (SF-36) (Ware 2001).
We also considered non-standardised measures, such as return to
work and goal attainment, if studies had included these as a mea-
sure of outcome. If more than one of these scales was reported for
each domain, we used the first scale in the list.
We classified all outcomes as immediate or longer-term outcomes,
and conducted separate analyses for each of these. We defined im-
mediate outcomes as shortly after the end of intervention, and
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longer-term outcomes as the second outcome following the im-
mediate outcome.
We used both total scores and individual domain scores, as ap-
propriate. We included domain scores, as some tests (such as the
Doors and People Test, Baddeley 1994) do not provide a total
score, but only domain-specific scores. In the event that several
types of scores were reported for various outcomes, we used the
following hierarchy: total profile scores over index scores (indices)
or composite scores over subtest scores.
Search methods for identification of studies
We conducted an electronic search with no restriction, and two
review authors (KJM, RdN) identified all potential studies.
Electronic searches
TheTrials SearchCo-ordinator searched theTrials SpecialisedReg-
ister of the Cochrane Multiple Sclerosis and Rare Diseases of the
CNS Group (2 June 2015), which contains the following:
• Cochrane Central Register of Controlled Trials
(CENTRAL) (2015 Issue 6).
• MEDLINE (PubMed) (1966 to 2 June 2015).
• EMBASE (EMBASE.com) (1974 to 2 June 2015).
• Cumulative Index to Nursing and Allied Health Literature
(CINAHL) (EBSCO host) (1981 to 2 June 2015).
• Latin American and Caribbean Health Science Information
Database (LILACS) (Bireme) (1982 to 2 June 2015).
• ClinicalTrials.gov.
• World Health Organization (WHO) International Clinical
Trials Registry Portal (http://apps.who.int/trialsearch/).
Information on the Trial Register of the Review Group and details
of search strategies used to identify trials can be found in the ’Spe-
cialised Register’ section within the Cochrane Multiple Sclerosis
and Rare Diseases of the CNS Group module.
The keywords used to search for studies for this review are listed
in Appendix 1.
We also searched the following databases:
• The NIHR Clinical Research Network database (2010 to
June 2015)
• PsycINFO (2011 to June 2015)
• Allied and Complementary Medicine Database (AMED)
(2010 to June 2015)
• British Nursing Index (2010 to June 2015)
• CAB Abstracts (2010 to June 2015)
Searching other resources
We citation tracked all primary study articles and scanned refer-
ence lists from book chapters and review articles. We also exam-
ined studies identified by the Rosti-Otajärvi 2011 and Thomas
2006 MS reviews for inclusion. We did not handsearch scientific
journals in this review, as until the early 1990s cognitive impair-
ments were not universally recognised as a common complaint
in MS (Rao 1991), and most RCTs have been reported (or up-
dated) on electronic databases or journals. Furthermore, we would
have found relevant trials from the search of the Cochrane Cen-
tral Register of Controlled Trials, for which handsearching is car-
ried out periodically, and we did not wish to duplicate this ef-
fort. Where necessary, we contacted authors of relevant trials to
enquire whether their registered trials had been published, and to
solicit more data where data required for the meta-analysis was
not presented in the published paper in a format that could be
used. We accessed grey literature by searching GreyNet (http:/
/www.greynet.org/) and the British Library’s EThOS database (
http://ethos.bl.uk/Home.do). Grey literature is “a field in Library
and Information Science that deals with the production, distribu-
tion, and access to multiple document types produced on all lev-
els of government, academics, business, and organization in elec-
tronic and print formats not controlled by commercial publishing
i.e. where publishing is not the primary activity of the producing
body” (GreyNet 2011).
Data collection and analysis
Selection of studies
One review author (RdN), developed the search strategy in consul-
tation with a senior librarian and the Cochrane Multiple Sclerosis
and Rare Diseases of the CNS Group. Two review authors (KJM,
RdN) evaluated abstracts of the studies obtained by this search
strategy, and identified trials for inclusion in the review using four
inclusion criteria (types of trials, participants, interventions, and
outcome measures). Another review author (NBL) cross-checked
the search strategy, independently appraised the protocol, and con-
firmed the inclusion and exclusion of studies.
Data extraction and management
Two review authors (RdN, KJM) independently assessed the
methodological quality of each of the selected trials and rated them
according to the guidelines of The Cochrane Collaboration. In
case of disagreement, the third review author (NBL) arbitrated,
and a verdict was reached. Our main considerations were whether
participant allocation had been random and adequately concealed,
and whether outcomes were performed blind to group allocation.
We conducted the review using the Cochrane Review Manager
software version 5.3 (RevMan 2015). The data extraction tool
employed by the das Nair and Lincoln Cochrane review, das Nair
2007a, was used in this study, and is therefore not replicated here.
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Assessment of risk of bias in included studies
Two authors (RdN, KJM) independently graded the included
trials and completed the ’Risk of bias’ table as described in the
Cochrane Handbook for Systematic Reviews of Interventions (Higgins
2011).
The table includes the following domains:
• Random sequence generation
• Allocation concealment
• Blinding (of participants, personnel, and outcome assessors)
• Incomplete outcome data
• Selective outcome reporting
• Other sources of bias
On the basis of the information provided in the studies or by
the authors of the primary studies, two review authors (RdN,
KJM) independently judged each of these domains as being low
or high risk of bias, or unclear if information was insufficient. Any
disagreements were arbitrated by another review author (NBL).
As review authors working in the field of memory rehabilitation
and are familiar with the studies published in this area, we could
not be blinded to the names of the authors, institutions, or the
publishing journal of the included trials. We made an evaluation
of the overall risk of bias, based on the relative importance of the
various domains listed. In addition to the ’Risk of bias’ table, the
review authors used the GRADE approach to assessing quality
of studies (GRADE Working Group 2004). This was completed
across outcomes and is found in the ’Summary of findings’ table.
This approach allows for judgements to made about the quality
of the studies included in each outcome.
Measures of treatment effect
We used odds ratio with 95% confidence intervals (CI) for the
binary outcomes.We used standardisedmean difference with 95%
CI for the continuous outcomes.
Unit of analysis issues
We included parallel-group, cluster-randomised, cross-over RCTs,
and quasi-RCTs, and included the data from all these types of
studies for the meta-analysis. For cross-over studies (as mentioned
under Types of studies section), we only included the pre-cross-
over phase of these trials. We did not combine the first and second
phases of the cross-over studies because of uncertainty about the
carryover effects in such trials, given that they are psychological
interventions, where the wash-out period is difficult to determine.
We included trials with more than two intervention groups, and
analysed them by pooling together the data on all the treatment
groups and compared them with the control group. If there was
more than one control group the results from the control groups
were pooled together and compared with treatment.
Dealing with missing data
Where data were not available from or unclear in the reports, we
contacted the correspondence author of the studies in question for
further information. We assessed the rates of attrition and missing
data from the included studies (where available) and explored how
these may have affected the results of the studies. We rated studies
as at high risk of bias if they had a postrandomisation attrition rate
of 30% or more (even if the intention-to-treat analysis was used).
Assessment of heterogeneity
We considered heterogeneity by comparing the distribution of
important participant factors between trials (age, gender, type of
MS), and trial factors (sequence generation, allocation conceal-
ment, blinding, losses to follow-up). We employed the I² statistic
to statistically assess heterogeneity (Higgins 2011; Huedo-Medina
2006). We further scrutinised the studies to explore the reasons
for the heterogeneity if the I² statistic was significant at >= 50%.
Data synthesis
We consulted the Cochrane Handbook for Systematic Reviews of
Interventions to plan the data synthesis (Higgins 2011), and fol-
lowed the procedures outlined therein. As most psychological and
neuropsychological outcome measures in memory rehabilitation
tend to be ordinal-level measures, we treated these as continuous
data (as recommended by Higgins 2011). Standardised mean dif-
ference was used as a summary statistic, as it was predicted that
multiple trials would employ various outcome measures to assess
memory. If low scores represented a better outcome, the valence
of the score was changed from positive to negative. In situations
where studies combined scores from scales in which high scores
are in some instances good outcomes and in some instances poor
outcomes, the signs of the discrepant scores were reversed to keep
them consistent. We considered only data that we deemed to be
similar or comparable enough tomeaningfully pool on the basis of
the outcome measures employed for the meta-analysis. Depend-
ing on the heterogeneity of the data, we considered fixed-effect or
random-effects models.
Subgroup analysis and investigation of heterogeneity
Weplanned subgroup analyseswhere at least two trials had separate
data available for people with different subtypes of MS.
Sensitivity analysis
We considered sensitivity analyses to assess the impact of study
quality (whether there was a difference between studies employ-
ing an intention-to-treat analysis and an on-treatment analysis)
where data needed to perform such analyses were available from
the included papers. We also considered a sensitivity analysis to
assess the influence of methodological quality on the intervention
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effect for each outcome by comparing the outcomes of those trials
with low risk of bias with the outcomes of all the included studies.
Following the Cochrane Handbook (Higgins 2011), we made only
informal comparisons, and did not conduct individual forest plots
for each sensitivity analysis, but provided a summary table.
R E S U L T S
Description of studies
Twelve studies were European (Austria, Denmark, Germany, Italy,
Norway, Spain, UK), and three were from the USA. All the Eu-
ropean studies were conducted at hospital clinics or rehabilitation
centres. One of the USA studies recruited participants from both
clinic and community settings; the other two USA studies did
not specify the exact location (Chiaravalloti 2005; Chiaravalloti
2013). The study from Italy was the only multicentre study (Solari
2004), with six Italian centres.
Results of the search
We identified a total of seven studies using the above-mentioned
search strategy. We eliminated articles based on the following ex-
clusion criteria:
1. not MS, or a mixed-aetiology group without at least 75% of
the sample being people with MS;
2. not a memory study, or did not have a separate memory
component if within the context of a larger “cognitive
rehabilitation” (or “cognitive retraining” or “neuropsychological
rehabilitation”) study;
3. not a rehabilitation intervention study; and
4. not an RCT.
Eight studies from the previous review were added to the seven
new studies in the final analysis. Please see Figure 1.
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Figure 1. Flow diagram showing article screening process
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Included studies
Fifteen studies, comprising a total of 989 participants, met the
inclusion criteria for this review (Chiaravalloti 2005; Chiaravalloti
2013; Carr 2014; das Nair 2012; Gich 2015; Hancock 2015;
Hanssen 2015;Hildebrandt 2007; Lincoln 2002;Mendozzi 1998;
Pusswald 2014; Solari 2004; Stuifbergen 2012; Tesar 2005), and
the Jønsson 1993 study was included in the review, but excluded
from the meta-analysis because the raw data was unattainable.
Solari 2004 was a multicentre trial, and employed a site-stratified
schedule. Hancock 2015 utilised a block-stratified randomisation
procedure to ensure that equal types of each MS subtype were
included in the intervention and control groups, and Gich 2015
stratified by level of cognitive impairment.
All but three studies mentioned the method of generating the
random schedule (Hancock 2015; Mendozzi 1998; Tesar 2005).
One study reported that randomisation was “performed by a lot-
tery by the director of the rehabilitation centre” (Hanssen 2015).
Three studies used quasi-randomisation: Chiaravalloti 2005 used
odd-even random allocation, andHildebrandt 2007 and Pusswald
2014 allocated by alternating between intervention and con-
trol. Six trials reported independent randomisation (Carr 2014;
Chiaravalloti 2013; das Nair 2012; Lincoln 2002; Solari 2004;
Tesar 2005), and Jønsson 1993 and Stuifbergen 2012 used a
closed-envelope method. Mendozzi 1998 randomised the first 30
participants, and purposefully assigned the last 30 to balance age,
gender, and education between groups; all data were included in
our analysis.
Participants were diagnosed with MS using the Poser crite-
ria, Poser 1983, in six studies, using the McDonald criteria,
McDonald 2001, in four studies (Chiaravalloti 2013; Hancock
2015; Hildebrandt 2007; Pusswald 2014), and the Schumacher
criteria, Schumacher 1965, in one study (Jønsson 1993). Four
studies did not report the criteria used to diagnose MS, but merely
stated that participants had clinically definite MS (Carr 2014; das
Nair 2012; Hanssen 2015; Stuifbergen 2012). Eleven studies in-
cluded participants with mixed types of MS (relapsing remitting
MS (RRMS) and secondary progressive MS (SPMS) in das Nair
2012; Gich 2015; Lincoln 2002; Mendozzi 1998; Tesar 2005;
and RRMS, SPMS, and primary progressive MS (PPMS) in Carr
2014; Chiaravalloti 2005; Chiaravalloti 2013; Hancock 2015;
Hanssen 2015; Jønsson 1993). One study included participants
with RRMS only (Hildebrandt 2007). The type of MS was not
reported in three studies (Pusswald 2014; Solari 2004; Stuifbergen
2012). The number of participants in the studies ranged from 19,
in Tesar 2005, to 240, in Lincoln 2002, and the number of par-
ticipants in treatment or control groups ranged from seven, in das
Nair 2012, to 82, in Lincoln 2002.Most participants were in their
40s. Varied gender ratios were reported, with percentage of women
ranging from 47%, in Jønsson 1993, to 87.5%, in Hancock 2015.
The participants had aminimum of elementary education inmost
studies, with the participants from the USA having the highest
number of years of education (15.57 in intervention, 15.61 in
control); Chiaravalloti 2013). One study did not report this de-
mographic variable (Tesar 2005). The groups were comparable
on assessed baseline characteristics in seven studies (Carr 2014;
Chiaravalloti 2013; Gich 2015; Hanssen 2015; Lincoln 2002;
Pusswald 2014; Tesar 2005), and in the other studies where differ-
enceswere observed, theywere statistically corrected (Chiaravalloti
2005; das Nair 2012; Hancock 2015; Hildebrandt 2007; Jønsson
1993; Solari 2004), with the exception of Mendozzi 1998 and
Stuifbergen 2012.
Twelve studies used two-group comparisons (treatment versus con-
trol), and three studies employed three-group comparisons (das
Nair 2012; Lincoln 2002; Mendozzi 1998). Lincoln 2002 used
assessment versus assessment plus feedback versus assessment plus
feedback and treatment; Mendozzi 1998 examined specific cogni-
tive retraining versus non-specific cognitive retraining versus con-
trol; and das Nair 2012 investigated restitution versus compensa-
tion versus self help control.
Eight studies used individual treatment (Gich 2015; Hancock
2015; Hildebrandt 2007; Jønsson 1993; Lincoln 2002; Mendozzi
1998; Pusswald 2014; Solari 2004), and six had group interven-
tions (Carr 2014; Chiaravalloti 2005; Chiaravalloti 2013; dasNair
2012; Stuifbergen 2012; Tesar 2005). One study used a mix of
both group and individual sessions (Hanssen 2015). The structure
and content of the treatment programmes varied. Most interven-
tions were of four to eight weeks duration (Chiaravalloti 2005;
Chiaravalloti 2013; Hancock 2015; Hanssen 2015; Hildebrandt
2007; Jønsson 1993; Lincoln 2002; Mendozzi 1998; Pusswald
2014; Solari 2004; Stuifbergen 2012; Tesar 2005). Carr 2014 and
das Nair 2012 had 10-week programmes, and Gich 2015 used a
six-month programme. The Lincoln 2002 study, having had in-
dividual treatment sessions, only specified the time frame for the
interventions (that is maximum six months’ postassessment). Ses-
sions ranged from 30minutes, in Hildebrandt 2007 and Pusswald
2014, and 2 hours, in Hanssen 2015, and participants met one to
three times a week in all studies except Mendozzi 1998, where the
treatment was bi-weekly.
In two studies, the contents of the treatment programmes were
individualised(Lincoln 2002; Hanssen 2015), depending on the
needs of the participants. Six studies used comprehensive mem-
ory rehabilitation programmes (including teaching participants
to use internal and external memory aids) (Carr 2014; das Nair
2012; Jønsson 1993; Lincoln 2002; Pusswald 2014; Tesar 2005).
Seven studies employed computerised memory- and attention-re-
training packages (Gich 2015; Hancock 2015; Hildebrandt 2007;
Mendozzi 1998; Pusswald 2014; Solari 2004; Stuifbergen 2012),
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and Chiaravalloti 2005 and Chiaravalloti 2013 used the Story
Memory Technique, which involved the use of imagery and story
generation. Studies that had a sham or attention placebo control
group reported having ensured that these groups had minimal
memory content, thereby reducing contamination (Chiaravalloti
2005; Chiaravalloti 2013; das Nair 2012; Hancock 2015; Jønsson
1993; Solari 2004).
The 15 included studies used a range of outcome measures. All
studies included at least one measure of learning or memory, with
the exception of Hanssen 2015, where outcomes were related to
psychological functioning and impact of disease.
Five studies used subjective measures of memory. Three studies,
Carr 2014, das Nair 2012, and Lincoln 2002, used the Every-
day Memory Questionnaire (EMQ) (Sunderland 1983), and das
Nair 2012 used Internal and External Memory Aids Question-
naires based on the Memory Aids Questionnaire (Wilson 1984);
one study, Chiaravalloti 2005, used the Memory Failures Ques-
tionnaire (MFQ) (Gilewski 1990); and one study, Stuifbergen
2012, used the Multiple Sclerosis Neuropsychological Question-
naire (MSNQ) (Benedict 2004).
Seven trials used list-learning tasks:HopkinsVerbal LearningTask-
Revised (HVLT-R) (Benedict 1998) (Chiaravalloti 2005); Verbal
Learning Test (VLT) (Sturm 1999a) (Tesar 2005); California Ver-
bal Learning Task-II (CVLT) (Delis 2000) (Chiaravalloti 2013;
Hildebrandt 2007; Stuifbergen 2012); Auditory Verbal Learning
Test (AVLT) (Lezak 2004) (Hancock 2015); Selective Reminding
Task (Gich 2015; Rao 1993); and the list-learning task used by one
study was not specified (Jønsson 1993). Six studies used neuropsy-
chological test batteries or subtests of these. One study, Mendozzi
1998, used the memory scale of the Luria-Nebraska Neuropsy-
chological Battery (LNNB) consisting of 13 items (Golden 1980).
Subtests from other test batteries included Buschke Selective Re-
minding Test from an Italian version of the Brief Repeatable Bat-
tery of Neuropsychological Tests (BRBNT) (Solari 2002), unspec-
ified tests from the Rivermead Behavioural Memory Test (RBMT-
E) (Wilson 1999), and theDoors andPeopleTest (Baddeley 1994).
Pusswald 2014 used the MUSIC assessment (Calabrese 2004),
and Jønsson 1993 used an unspecified battery. Non-verbal mem-
ory was assessed using individual tests or part of a battery. In-
dividual tests included the Noverbaler Lerntest (NVLT) (Sturm
1999b) (Tesar 2005), and an unspecified 50-faces recognition test
(Jønsson 1993).
The most frequently usedmood measure was the BeckDepression
Inventory (BDI) (Beck 1987), used in four studies (Chiaravalloti
2005; Hancock 2015; Hildebrandt 2007; Tesar 2005). Three
studies, Carr 2014, das Nair 2012, and Lincoln 2002, used the
General Health Questionnaire (GHQ-28) (Goldberg 1988); one,
Chiaravalloti 2013, used the Chicago Mood Depression Inven-
tory (CMDI) (Nyenhuis 1998); and another, Solari 2004, used
the Italian version of the CMDI (Solari 2003).
Three studies (Hancock 2015; Solari 2004; Lincoln 2002) as-
sessed quality of life using the Multiple Sclerosis Quality of Life
(MSQOL-54; Vickrey 1995), and two studies, Carr 2014 and
Hanssen 2015, used the Multiple Sclerosis Impact Scale (MSIS-
29) (Hobart 2001).
Only two studies examined whether their rehabilitation pro-
gramme had an effect on instrumental ADL (das Nair 2012;
Lincoln 2002), by using the Extended Activities of Daily Living
scale (EADL) (Nouri 1987). Chiaravalloti 2013 assessed func-
tional independence with the Functional Assessment of Multiple
Sclerosis (FAMS) (Cella 1996).
Nine studies were observer-blinded RCTs or quasi-randomised
trials (Carr 2014; das Nair 2012; Gich 2015; Hildebrandt 2007;
Jønsson 1993; Lincoln 2002; Mendozzi 1998; Stuifbergen 2012;
Tesar 2005), and four were observer- and participant-blinded
(Chiaravalloti 2005; Chiaravalloti 2013; Hancock 2015; Solari
2004). One study reported that blinding of participants was not
possible due to the nature of the intervention, and there was no
mention of observer blinding (Hanssen 2015). However, all out-
comes were self report questionnaire-based, therefore blinding was
not deemed necessary. One study reported that outcome assessors
were not blinded (Pusswald 2014). Outcomes were assessed by an
individual blind to treatment allocation in all studies, with the
exception of four (Hanssen 2015; Jønsson 1993; Pusswald 2014;
Tesar 2005).
Excluded studies
We excluded 33 studies on the basis of the exclusion criteria spec-
ified for this review. Two were studies of Alzheimer’s disease, not
MS (Akhtar 2006; Loewenstein 2004); four were not related to
memory (comparative study of Barthel Index andFunctional Inde-
pendenceMeasure in van der Putten 1999, and falls in Aisen 1994,
Canellopoulou 1998, and Flavia 2010); and one was a systematic
review, not an intervention study (Thomas 2006). Five studies
were not specific to memory, but general neuropsychological re-
habilitation, attention, or information processing (Amato 2014;
Goreover 2011; Mattioli 2012; Mäntynen 2014; Rosti-Otajärvi
2013a; Rosti-Otajärvi 2013b). Three studies used healthy controls
instead of an MS control group (Ernst 2013; Vogt 2009; Wilson
2001), and Wilson 2001 also did not distinguish between results
for people with MS and others with acquired progressive brain
injury. Seven studies were not RCTs or quasi-RCTs (one quasi-
experimental waiting-list control: Rodgers 1996; one small group
study: Allen 1998; one involving a healthy control group: Aldrich
1995; two without random allocation: Brenk 2008; Brissart 2013;
one with no control group: Brissart 2010; and two with healthy
controls: Chiaravalloti 2003; Ernst 2013). One study was a brain
imaging study and had an active control group (Bonavita 2015).
One study used a “music intervention” (Thaut 2014). One study
was not considered to be a rehabilitation study according to out
inclusion criteria because it only involved one hour-long ses-
sion of memory retraining (Moore 2008). Three studies used the
same sample, or a subgroup of the sample, of Chiaravalloti 2013
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(Chiaravalloti 2012; Dobryakova 2014; Leavitt 2012), and an-
other, Martin 2014, was a subgroup analysis of das Nair 2012,
and was therefore not included. Finally, one study was a confer-
ence poster presentation, and no full text could be found (Nurova
2014).
Risk of bias in included studies
The risk of bias in the 15 included studies was generally low
(see Figure 2 and Figure 3), with some high risk of selection
bias and detection bias associated with random sequence gen-
eration in four studies (Chiaravalloti 2005; Hildebrandt 2007;
Mendozzi 1998; Pusswald 2014), allocation concealment in two
studies (Chiaravalloti 2005; Hanssen 2015), lack of blinding in
two studies (Pusswald 2014; Tesar 2005), incomplete outcome
data in two studies (Chiaravalloti 2013; Hancock 2015), and
possible selective reporting in one study (Hancock 2015). We
judged the risk of bias to be unclear in some instances mainly
due to insufficient reporting of the methods used for random
sequence generation (Gich 2015; Hanssen 2015; Jønsson 1993;
Tesar 2005), allocation concealment (Gich 2015; Hancock 2015;
Hildebrandt 2007; Mendozzi 1998; Pusswald 2014), blinding
(Hanssen 2015; Jønsson 1993), andhandling incomplete outcome
data (Chiaravalloti 2005; Hanssen 2015; Jønsson 1993;Mendozzi
1998; Pusswald 2014; Tesar 2005).
Figure 2. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
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Figure 3. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Random sequence generation
Four studies were judged to have a low risk of selection bias due
to having adequate random sequence generation, having used a
computerised random number generator by an independent unit
(Carr 2014; Chiaravalloti 2013; das Nair 2012; Lincoln 2002;
Solari 2004) and one used a random number generator from the
study data analyst that was created prior to recruitment and kept
in sealed envelopes (Stuifbergen 2012). Four studies were judged
not to have adequate sequence generation and therefore a high
risk of bias as themethods involved were quasi-random ’odd-even’
or alternating allocation (Chiaravalloti 2005; Hildebrandt 2007;
Pusswald 2014), and one study only randomised half the sample
with no generation method stated (Mendozzi 1998). The method
used for random sequence generation and the risk of bias in four
other studies was unclear (Gich 2015; Hanssen 2015; Jønsson
1993; Tesar 2005).
Allocation
We judged eight studies to have a low risk of selection bias due to
effectively concealing allocation into groups using a computerised
random number generator by an independent unit (Carr 2014;
Chiaravalloti 2013; das Nair 2012; Lincoln 2002; Solari 2004),
a closed envelope system (Jønsson 1993; Stuifbergen 2012), or
having a separate staff member who was not otherwise involved
in the study complete allocation (Tesar 2005). We judged two
studies as not having concealed allocation to groups, suggesting a
high risk of bias: one having used “odd-even” allocation completed
by the principal investigator (Chiaravalloti 2005), and one stat-
ing that allocation concealment was not possible (Hanssen 2015).
Five studies were unclear in their explanation of allocation con-
cealment: one informing participants whether they were to receive
the intervention or assessment only (Hildebrandt 2007); one in
which the principal investigator allocated groups and what other
involvement he or she had in the study was not clearly explained
(Mendozzi 1998); and three studies not mentioning allocation
concealment (Gich 2015; Hancock 2015; Pusswald 2014).
Blinding
Seven studies were observer blinded (Carr 2014; das Nair 2012;
Gich 2015; Hildebrandt 2007; Lincoln 2002; Mendozzi 1998;
Stuifbergen 2012), and four were double blind (Chiaravalloti
2005; Chiaravalloti 2013; Hancock 2015; Solari 2004), there-
fore suggesting a low risk of performance and detection bias. One
study reported that blinding of participants was not possible due
to the nature of the intervention (Hanssen 2015), and there was
no mention of observer blinding, but because the outcomes were
self report questionnaire based, we deemed this study to have an
unclear risk of bias. Two studies did not use any blinding proce-
dures, suggesting a high risk of bias (Pusswald 2014; Tesar 2005),
and another was unclear in its description of the methodology
used (Jønsson 1993).
Incomplete outcome data
We deemed two studies to be at high risk of attrition bias: in one
study (Chiaravalloti 2013), there were multiple dropouts but no
discussion of how missing data were dealt with, and the study
did not employ intention-to-treat analysis; in the other study,
the postrandomisation attrition level was 44% (Hancock 2015).
Five studies did not address incomplete outcome data, which we
deemed to be at unclear risk of bias: two studies did not use inten-
tion-to-treat analysis and reported one dropout, in Chiaravalloti
2005, and two dropouts, in Hanssen 2015; in another, participant
outcome data were replaced with mid-trial data if a participant
dropped out (Mendozzi 1998); and two studies did not explain
how drop-out data were handled (Jønsson 1993; Tesar 2005). One
study conducted analyses on data for those participants who com-
pleted the outcome assessments (Lincoln 2002), one used list-
wise deletion and baseline data imputed for any missing follow-up
data (das Nair 2012), and in two studies (Solari 2004; Stuifbergen
2012), missing values were imputed according to the last observa-
tion carried forward method. In one study, where less than 10%
of items were missed on a questionnaire, these were replaced with
the mean for the questionnaire (Carr 2014).
Selective reporting
We deemed one study to have a high risk of reporting bias
(Hancock 2015), as the paper only reported on the memory out-
comes, despite other outcomes having been assessed at follow-up,
and data were only reported for “good adherers” to the interven-
tion.
Other potential sources of bias
We judged14 studies to have a low risk of other potential sources of
bias (Carr 2014; Chiaravalloti 2005; Chiaravalloti 2013; das Nair
2012; Gich 2015; Hancock 2015; Hanssen 2015; Hildebrandt
2007; Jønsson 1993; Lincoln 2002; Pusswald 2014; Solari 2004;
Stuifbergen 2012; Tesar 2005). One study had a potential source
of bias, as one participant in the treatment group discontinued
cognitive retraining and was replaced by a new entry without fur-
ther explanation (Mendozzi 1998).
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Effects of interventions
See: Summary of findings for the main comparison Memory
rehabilitation for people with multiple sclerosis
In this section, we first present study-specific information regard-
ing intervention effect on memory outcomes, and then present
the meta-analysis, synthesising results on various domains.
Seven studies concluded that there were no significant differences
between the treatment and control groups on measures of mem-
ory, particularly after adjustments were made for multiple testing
(Carr 2014; Chiaravalloti 2005; das Nair 2012; Hancock 2015;
Jønsson 1993; Lincoln 2002; Solari 2004). Seven studies reported
significant differences on memory measures favouring the treat-
ment groups (Chiaravalloti 2013; Gich 2015; Hildebrandt 2007;
Mendozzi 1998; Pusswald 2014; Stuifbergen 2012; Tesar 2005).
One study did not use memory outcomes (Hanssen 2015). Gich
2015 reported significant differences favouring treatment on some
subtests of the BRBN (Rao 1993), although no significant differ-
ences were reported on the list-learning task of the BRBN used in
this meta-analysis. Hildebrandt 2007 reported improvements for
the treatment group in the Learning Trials and Long Delay Free
Recall subtests of the CVLT (Niemann 2003). Stuifbergen 2012
reported improvements in the CVLT total both over time and by
group, and showed significantly more use of memory strategies
in the intervention compared with control. Chiaravalloti 2013
showed a greater learning slope for the treatment group com-
pared to the control on the CVLT-II (Delis 2000). Tesar 2005
reported improvements on the computer-aided card-sorting test
(CKV), Drühe-Wienholt 1998, and the Mosaic Test of the Ham-
burg Wechsler Intelligence Test (HAWIE-R), Tewes 1991, for the
treatment group. Chiaravalloti 2005 observed no significant dif-
ference between the treatment and control groups on their list-
learning task (HVLT-R) (Benedict 1998), but on subgroup anal-
ysis, we observed significant improvement on this task for the
moderate-to-severe memory-impaired subgroup, but not for other
groups. However, this subgroup analysis was carried out only on
the treatment group, which had 14 participants. Mendozzi 1998
reported improvement in the specific cognitive-retraining group
on seven measures of memory (Spatial Span from the Corsi, Digit
Span Forward and Backward, Visual Reproduction, and Paired
Associates-Hard from the ItalianWeschlerMemory Scale (WMS),
Wechsler 1945, and the LNNB, Golden 1980. There was an im-
provement in Digit Span Forward only in the non-specific cogni-
tive rehabilitation group.
Outcome 1: Subjective memory measures
Five studies included subjective measures of participants’ immedi-
ate and long-term memory functioning (Carr 2014; Chiaravalloti
2005; das Nair 2012; Lincoln 2002; Stuifbergen 2012). Three of
these studies, Carr 2014, das Nair 2012, and Lincoln 2002, used
the EMQ (Sunderland 1983); one, Stuifbergen 2012, used the
MSNQ (Benedict 2004); and one, Chiaravalloti 2005, used the
MFQ (Gilewski 1990). However, we found no significant effect
of treatment on subjective reports of memory either immediately
(standardised mean difference (SMD) of 0.04 (95% CI -0.19 to
0.27) P = 0.73) Analysis 1.1 or long term (SMD of 0.04 (95% CI
-0.19 to 0.27) P = 0.71) Analysis 1.2.
Outcome 2: Objective memory measures
Eleven studies included objective measures of memory imme-
diately after treatment (Chiaravalloti 2005; Chiaravalloti 2013;
das Nair 2012; Gich 2015; Hancock 2015; Hildebrandt 2007;
Mendozzi 1998; Pusswald 2014; Solari 2004; Stuifbergen 2012;
Tesar 2005), and six of these studies examined long-term effects of
treatment (Chiaravalloti 2005; Chiaravalloti 2013; das Nair 2012;
Solari 2004; Stuifbergen 2012; Tesar 2005). The outcome mea-
sures used were idiosyncratic to each study. We found significant
differences between intervention and control in objective mem-
ory measures at both immediate and long-term follow-ups, with
a SMD of 0.23 (95% CI 0.05 to 0.41) P = 0.01 Analysis 2.1 and
SMD of 0.26 (95% CI 0.03 to 0.49) P = 0.03 Analysis 2.2, re-
spectively. The intervention group performed significantly better
than the control on both immediate and long-term follow-ups.
Outcome 3: Mood
Nine studies included measures of participants’ mood immedi-
ately after treatment (Carr 2014; Chiaravalloti 2005; Chiaravalloti
2013; das Nair 2012; Hancock 2015; Hildebrandt 2007; Lincoln
2002; Solari 2004; Tesar 2005), and seven of these studies exam-
ined long-term effects on mood (Carr 2014; Chiaravalloti 2005;
Chiaravalloti 2013; das Nair 2012; Lincoln 2002; Solari 2004;
Tesar 2005). Four studies, Chiaravalloti 2005, Hancock 2015,
Hildebrandt 2007, and Tesar 2005, used the BDI (Beck 1987),
three, Carr 2014, das Nair 2012, and Lincoln 2002, used the
GHQ (Goldberg 1988), and two, Chiaravalloti 2013 and Solari
2004, used the CMDI (Nyenhuis 1998). However, we found no
significant effect of treatment on mood either immediately (SMD
of 0.02 (95% CI -0.16 to 0.20) P = 0.81) Analysis 3.1 or long
term (SMD of -0.01 (95% CI -0.21 to 0.20) P = 0.96) Analysis
3.2.
Outcome 4: Functional abilities / Activities of daily living
(ADL)
Two studies included measures of participants’ ADL immediately
after treatment and long term (das Nair 2012; Lincoln 2002).
Both studies used the EADL (Nouri 1987). However, we found no
effect of treatment on ADL immediately (SMD of -0.13 (95% CI
-0.60 to 0.33) P = 0.57) Analysis 4.1, and at the long-term follow
up it appeared that the intervention group performed worse than
the control group (SMD of -0.33 (95% CI -0.63 to -0.03) P =
0.03) Analysis 4.2.
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Outcome 5: Quality of life (QoL)
Seven studies included measures of participants’ QoL immedi-
ately after treatment (Carr 2014; Chiaravalloti 2013; Hancock
2015; Hanssen 2015; Hildebrandt 2007; Lincoln 2002; Solari
2004), and five of these studies examined the long-term ef-
fects on QoL (Carr 2014; Chiaravalloti 2013; Hanssen 2015;
Lincoln 2002; Solari 2004). Two studies used the 36-Item Short
Form Health Survey (SF-36) (Ware 2001), one used the Men-
tal Health composite score from the SF-36 (Lincoln 2002) and
one, Hildebrandt 2007, calculated a mental score using the 12-
Item Short Form Health Survey (SF-12) (Bullinger 1998). Two
studies, Carr 2014 and Hanssen 2015, used the MSIS-29(Hobart
2001), one, Chiaravalloti 2013, used the FAMS(Cella 1996), and
two studies, Hancock 2015 and Solari 2004, used the MSQOL-
54(The WHOQOL Group 1993). We found a significant effect
on the immediate follow-up (SMD 0.23 (95% CI 0.05 to 0.41)
P = 0.01), showing the intervention group to have significantly
higher scores for QoL compared with the control group Analysis
5.1. We found no significant effect of treatment at the long-term
follow-up (SMD 0.16 (95% CI -0.03 to 0.36) P = 0.11) Analysis
5.2.
D I S C U S S I O N
Summary of main results
In the last two decades research groups from Europe and North
America have begun to address memory problems associated with
MS. However, the literature base examining the effectiveness of
memory rehabilitation for MS is weak. While single-case and un-
controlled studies have found memory rehabilitation to be effec-
tive in reducing memory or psychological problems, these results
have not been consistently replicated in RCTs.
We included 15 RCTs or quasi-randomised trials in this review.
These studies were either memory rehabilitation studies or cogni-
tive rehabilitation trials with a specific memory component that
included a memory intervention. These trials were mostly of rel-
atively poor quality, with many still not adhering to the Con-
solidated Standards of Reporting Trials (CONSORT) guidelines
(Moher 2001).Descriptions of the randomisation protocol, blind-
ing, and content of treatment and control groups were poor in
most studies.
Studies generally had modest sample sizes, and used impairment-
level outcome assessments to determine the effectiveness of the
intervention. One limitation was we could only obtain informa-
tion onwhether the studies used intention-to-treat or per-protocol
analyses for six studies (Carr 2014; das Nair 2012; Hildebrandt
2007; Lincoln 2002; Solari 2004; Stuifbergen 2012), therefore we
could not complete a sensitivity analysis of intention-to-treat in
comparison with per-protocol analysis. However, we were able to
conduct a sensitivity analysis comparing studies judged to be at
low risk of bias to all included studies (see Table 1). Our interpre-
tation of the sensitivity analysis suggests that while the quality of
the trials did not affect most outcomes, some differences were ob-
served in the objective memory outcomes (both at immediate and
long term) and quality of life (immediate) outcome, with studies
with higher risk of bias inflating the overall effect size estimates for
these outcomes, and the test of overall effect changing from being
statistically significant to not significant when studies at high risk
of bias were excluded. This suggests that lower-quality studies may
have positively influenced the outcomes. Only one study had a
large sample size and sufficient data available to complete a sub-
group analysis (Lincoln 2002). A subgroup meta-analysis on the
basis of type of MS will therefore need to be completed in a future
review update when more studies become available.
Seven individual studies reported positive results on memory out-
comes from their memory rehabilitation groups (Chiaravalloti
2005; Gich 2015; Hildebrandt 2007; Mendozzi 1998; Pusswald
2014; Stuifbergen 2012; Tesar 2005). However, these results need
to be interpreted in the context of the methodological limitations
and the measures used to assess effectiveness, which may have in-
fluenced the outcome. In fact, most of the studies that reported
a positive memory outcome for the intervention groups were also
rated as having a high or unclear risk of bias. Two well-designed
studies with larger sample sizes did not find evidence of effective-
ness of cognitive or memory rehabilitation for people with MS
(Lincoln 2002; Solari 2004). Indeed, one study, Lincoln 2002,
found that the intervention group performed worse than the con-
trol group on the EADL (Nouri 1987) scale assessed at long-term
follow up, which contributed to an overall SMDof -0.33, suggest-
ing control performed significantly (P = 0.03) better than inter-
vention on ADL.However, this difference, the authors state, could
have been caused by chance occurrences resulting from uneven
randomisation. We could not control for this variable (EADL) as
a covariant, because baseline scores on this measure were not avail-
able. Other individual studies found significant effects favouring
the treatment relating to mood, in Chiaravalloti 2013, das Nair
2012, and Jønsson 1993, and QoL, Chiaravalloti 2013 and Solari
2004.
The results of this review suggest there is some evidence to support
the effectiveness of memory rehabilitation on objective memory
tests or observer-rated measures of memory. However, this needs
to be viewed in relation to the quality of the evidence for this
outcome, with the GRADE rating showing as very low for imme-
diate follow-up, and low for long-term follow-up. Furthermore,
improvements seen for the intervention groups were on outcome
measures that assessed function at an impairment level, that is
mainly list-learning tasks. The degree to which this has the po-
tential to generalise to everyday life, given the lack of ecological
validity of these tests, is questionable. Results also suggest that
treatment groups had better QoL scores immediately after the in-
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tervention, but this was not maintained at long-term follow-up.
Other results of this review suggest there is insufficient evidence
to support or refute the effectiveness of memory rehabilitation on
subjective memory tests. However, again, it is important to note
the methodological quality on the GRADE rating was shown to
be moderate for these outcomes.
Quality of the evidence
The literature-base examining the effectiveness of memory reha-
bilitation for people with MS is poor. We identified only 15 RCTs
of memory rehabilitation for people with MS, and all but two
had small sample sizes (Hanssen 2015; Lincoln 2002). However,
studies included in this review were more methodologically sound
than the memory rehabilitation RCTs included in systematic re-
views of stroke or traumatic brain injury literature (das Nair 2007a;
das Nair 2007b). This may be because most of these studies were
conducted after the publication of the CONSORT statement and
guidelines (Moher 2001). However, the guidelines were not al-
ways followed in these trials. The randomisation protocol was in-
adequate and was poorly reported for four studies (Chiaravalloti
2005; Hildebrandt 2007; Mendozzi 1998; Pusswald 2014). Gich
2015, Hanssen 2015, and Tesar 2005 did not clearly mention
how the randomisation list was created or what procedures were
undertaken; Jønsson 1993 used closed envelopes, but did not
mention who created the random lists; Chiaravalloti 2005 em-
ployed odd-even random allocation; and Hildebrandt 2007 and
Pusswald 2014 used alternating allocation. These two latter forms
of allocation are not technically considered acceptable to qual-
ify as an RCT (Glanville 2006), but are classed by Cochrane as
a quasi-randomised trial (Higgins 2011), and were therefore in-
cluded in this review. Mendozzi 1998 randomised only half the
sample, with no stated random generation method. Seven stud-
ies reported their randomisation protocols adequately (Carr 2014;
Chiaravalloti 2013; das Nair 2012; Hancock 2015; Lincoln 2002;
Solari 2004; Stuifbergen 2012). Issues related to the success of
blinding were not appropriately reported in the included studies,
with the notable exception of Solari 2004, who stated how this was
assessed. Jønsson 1993 acknowledged that adequate blinding was
not possible in their trial. The studies we have added in this update
have only marginally improved in terms of quality of reporting of
trials (Carr 2014; Chiaravalloti 2013; Gich 2015; Hancock 2015;
Hanssen 2015; Pusswald 2014; Stuifbergen 2012). This suggests
that more work is needed to ensure that trialists follow the CON-
SORT statement (Moher 2001).
Furthermore, given that memory rehabilitation is a complex in-
tervention (Craig 2008), much more detail is required about what
participants experience in both the intervention and the control
arms of the trial. Indeed, the description of the interventions was
inadequate in most studies, and control groups were even less
well described. Recently published guidelines such as the Tem-
plate for Intervention Description and Replication (TIDieR) and
the Criteria for Reporting the Development and Evaluation of
Complex Interventions in healthcare: revised guideline (Hoffman
2014; Möhler 2015), alongside more specific guidance for mem-
ory rehabilitation (Martin 2015), may help improve the quality of
reporting of trials of complex interventions.
Inclusion and exclusion criteria were relatively well-defined, with
all studies except three, Carr 2014, Hanssen 2015 and Stuifbergen
2012, employing the McDonald 2001, Poser 1983, Schumacher
1965 (or later) criteria to establish a diagnosis of MS. The three
studies that did not use the above criteria did not mention how
the diagnosis of MS was confirmed (Carr 2014; Hanssen 2015;
Stuifbergen 2012). While most studies described the flow of par-
ticipants through the trial, one did not (Tesar 2005), and only
11 of the 15 studies had flowcharts (Carr 2014; Chiaravalloti
2005; Chiaravalloti 2013; das Nair 2012; Gich 2015; Hancock
2015; Hanssen 2015; Lincoln 2002; Pusswald 2014; Solari 2004;
Stuifbergen 2012).
The selection of outcome measures was poor, with most trials hav-
ing opted for impairment-level measures or tests with modest eco-
logical validity and minimal chance of generalisation of treatment
effects to ADL. Only five studies employed subjective measures of
memory (Carr 2014; Chiaravalloti 2005; das Nair 2012; Lincoln
2002; Stuifbergen 2012), which had some degree of ecological va-
lidity and were activity-level measures. However, these are prone
to subjective reporting biases common to most Patient-Reported
OutcomeMeasures (PROMs). Furthermore, another aspect of va-
lidity that should be considered relates to the cultural appropriate-
ness of outcomes, which takes into account not only translation
and adaptation of assessment tools, but also their validation.
Both parametric and nonparametric statistical tests were used
to compare groups. Change scores were compared in five stud-
ies (Chiaravalloti 2005; Chiaravalloti 2013; Gich 2015; Hanssen
2015; Stuifbergen 2012), and all studies were concerned with sig-
nificance testing. However, exact P values were only mentioned
in seven trials (Carr 2014; das Nair 2012; Gich 2015; Hancock
2015; Lincoln 2002; Pusswald 2014; Solari 2004), with one trial
providing all P values in tables that were readily accessible online
as supplementary information (Chiaravalloti 2013). Three stud-
ies mentioned confidence intervals (Chiaravalloti 2005; Lincoln
2002; Solari 2004), and Lincoln 2002 and Solari 2004 also re-
ported the post-hoc tests or statistical corrections or adjustments
performed on their data. Six studies used intention-to-treat analy-
sis (Carr 2014; das Nair 2012; Hildebrandt 2007; Lincoln 2002;
Solari 2004; Stuifbergen 2012).
Only two studies reported feedback from the participants (Carr
2014; Tesar 2005), both of which used a feedback questionnaire.
The feedback obtained was positive.
Potential biases in the review process
Two of the review authors were lead investigators for two of the
included studies (das Nair 2012, Lincoln 2002), and named au-
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thors on another included study (Carr 2014).
Other limitations of the review were that we only searched for pa-
pers in English, and we could only include mixed-diagnosis stud-
ies where separate data for those participants with MS were pro-
vided. Therefore, there may be more data available that we did
not have access to. There were also potential overlaps between at-
tention and memory retraining, where an intervention could be
described as attention when it actually addressed memory, but to
mitigate this we checked papers at full-text review to ensure that
they were not excluded if a memory component was presented
as part of the treatment. Finally, we searched GreyNet and the
EThOS databases; however, we are not sure of the comprehen-
siveness of these, thus creating the possibility of further relevant
grey literature that was not obtained via the searches.
Agreements and disagreements with other
studies or reviews
This review complements the ’Psychological interventions for
multiple sclerosis’ intervention review (Thomas 2006). In one of
their mini-reviews, Thomas 2006 found “some evidence of ef-
fectiveness of cognitive rehabilitation on cognitive outcomes, al-
though this was difficult to interpret because of the large number
of outcome measures used”. Their interpretations have therefore
been based on a narrative review of results from individual stud-
ies. The Thomas 2006 review covered interventions that were not
specific to ’memory rehabilitation’, however, their findings related
to effectiveness of interventions to help people with cognitive im-
pairments were inconclusive.
Similarly, the Rosti-Otajärvi 2011 review found evidence that
memory span, working memory, and delayed memory were sig-
nificantly improved for the treatment compared with the control
group. However, their review found no significant differences be-
tween intervention and control for emotional functions, whereas
this review has found some significant differences, notably QoL
and ADL. Any discrepancies are likely due to the differences in
inclusion criteria, as this review was specific to memory rehabil-
itation, or a cognitive rehabilitation with a memory component,
whereas the Rosti-Otajärvi 2011 review evaluated a much larger
breadth of neuropsychological interventions and outcomes.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
In the last two decades increasing attention has been given to
memory problems as a frequent complaint for people with MS.
Memory rehabilitation programmes are offered to some people
withMS, but their effectiveness has been questionable. Small stud-
ies employing a mixture of internal and external memory aids,
errorless learning, and environmental manipulation have yielded
positive results. This review examined the evidence from RCTs
and quasi-RCTs and found some evidence to suggest that mem-
ory rehabilitation is effective in improving memory performance
on objective assessments across immediate and long-term follow-
ups, but found no difference between intervention and control in
subjective memory measures. Some improvement was also shown
in quality of life for the intervention group at immediate follow-
up. However, given the methodological limitations, and the low
GRADE scores for significant outcomes,more research is required.
There appeared to be no indication of harm caused by the inter-
ventions, but it must be noted that studies did not routinely report
adverse effects.
Implications for research
The research base from which to draw inferences for clinical prac-
tice regarding the effectiveness of memory rehabilitation for MS
is both quantitatively and qualitatively poor, but it has marginally
improved since the previous review (das Nair 2012). RCTs, when
conducted, tend to be of modest sample size, and mostly utilise
impairment-level outcome measures, which have limited value in
assessing the effectiveness of neurorehabilitation. These trials do
not always adhere to the CONSORT guidelines (Moher 2001),
which makes it difficult to get a full and true picture of the studies,
and therefore limits the reader from making an informed decision
regarding the fidelity of their conclusions. Missing information
from such reports alsomake collating information for ameta-anal-
ysis difficult. Furthermore, results from positive trials may be diffi-
cult to implement in clinical practice if sufficient details about the
actual intervention are not clearly spelt out. The TiDieR checklist
and other more specific guidance for reporting of memory reha-
bilitation trials may help improve the quality of reporting trials of
complex interventions (Hoffman 2014;Martin 2015). The results
of this review indicate that more research is required to arrive at a
definitive answer as to whether or not memory rehabilitation for
MS is effective in reducing disability. It also highlights the need for
more well-conceptualised, executed, and reported RCTs of mem-
ory rehabilitation that take into consideration the issues raised in
this review.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Carr 2014
Methods Single-blind RCT, randomisation by off-site independent randomisation centre, com-
puter generated random number sequence
Participants n = 48 (E: 24, C: 24)
Mean age E: 55.8, C: 52.9
Mean years of education E: 15.7, C: 13.5
Interventions Group format, 10 sessions, each 1.5 hours long. Sessions included both compensation
and restitution, including memory education, strategies to help focus attention, internal
memory strategies, use of external aids
Outcomes Intention-to-treat analysis used
No significant differences between groups at 4 or 8 months on EMQ, MSIS-29. Ex-
perimental group scored better than control on GHQ-28 at 8 months’ follow-up, no
difference at 4 months
Notes RCT: Randomised controlled trial, E: Experimental, C: Control, EMQ: EverydayMem-
oryQuestionnaire, MSIS-29:Multiple Sclerosis Impact Scale,GHQ-28: GeneralHealth
Questionnaire
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote “computer generated list prepared
in advance of the study and held by an in-
dependent researcher at the University of
Nottingham”
Allocation concealment (selection bias) Low risk See above
Blinding (performance bias and detection
bias)
All outcomes
Low risk Postal outcomes that were “scored by a re-
searcher blind to group allocation”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Intention to treat used. If less than 10%
of items missed, these were replaced with
mean for questionnaire
Selective reporting (reporting bias) Low risk All outcomes analysed and reported
Other bias Low risk None identified
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Chiaravalloti 2005
Methods Odd-even random allocation
Participants kept blind to treatment
Participants n = 29
Randomised (E: 15, C: 14)
Completed: (E: 14, C: 14)
Age: 45 to 46 years
Education: 14 to 15 years
Groups comparable on all but duration of illness variable (E: group longer disease dura-
tion)
Interventions Group format
8 sessions (45-min sessions, 2/week)
E: SMT (imagery and story)
C: reading story and recall without SMT
Outcomes Intention-to-treat analysis not used
Non-significant results of group or time on HVLT-R, STAI, BDI
Significant difference on MFQ (E > C); but subgroup analysis: significant difference in
learning ability (HVLT-R) at follow-up 1 and 2 for moderate-severe group (E > C)
Notes E: Experimental; C: Control; SMT: Story Memory Technique; HVLT-R: Hopkins Ver-
bal Learning Test-Revised; STAI: State Trait Anxiety Inventory; BDI: Beck Depression
Inventory; MFQ: Memory Functioning Questionnaire
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Quasi-random “odd-even” allocation
Allocation concealment (selection bias) High risk Odd/even allocation by primary investiga-
tor
Blinding (performance bias and detection
bias)
All outcomes
Low risk Participants and assessors had no knowl-
edge of group allocation
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Intention to treat not used. 1 dropout
Selective reporting (reporting bias) Low risk No selective reporting apparent
Other bias Low risk None identified
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Chiaravalloti 2013
Methods Double-blind, placebo-controlled, randomised controlled trial
Participants n = 86 (E: 41, C: 45)
Groups similar in demographic and disease characteristics, disease-modifying therapy,
pretreatment cognition, and emotional symptomatology
Interventions mSMT, 10 sessions over 5 weeks (2 per week)
Session length 45 minutes to 1 hour, focused on imagery and context
2 sessions on applying mSMT to real-life scenarios
Outcomes Intention-to-treat analysis not used.
Immediate follow-up: E group showed greater learning slope on CVLT (P = 0.007), E
also showed significant improvement from baseline to follow-up on CVLT slope (P =
0.009). Significant differences (E > C) on RBMT story, FAMS general contentment,
FrSBe
Long-term follow-up: Decline in CVLT slope from immediate to 6 months’ follow-up.
Significant difference (E > C) on FAMS general contentment
Notes E: Experimental; C: Control; mSMT: modified Story Memory Technique; CVLT: Cal-
ifornia Verbal Learning Task; RBMT: Rivermead Behavioural Memory Test; FAMS:
Functional Assessment of Multiple Sclerosis; FrSBe: Frontal Systems Behaviour Scale
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “computerised random number generator
... the individual responsible for group as-
signment was not otherwise involved in
data collection and group assignment was
verified by a second individual via duplicate
copy of the randomization table generated
before initiation of data collection”
Allocation concealment (selection bias) Low risk “treatment allocation was concealed”
Blinding (performance bias and detection
bias)
All outcomes
Low risk “All RAs conducting assessments were
blinded to group membership”. Masking
details given. Participants also blinded to
group allocation
Incomplete outcome data (attrition bias)
All outcomes
High risk 88 were randomised (E = 46, C = 42), but
immediate outcomes were for E = 45, C =
41, and long term outcomeswere for E = 40
and C = 38. No intention-to-treat analysis
Selective reporting (reporting bias) Low risk Tables given as supplement to all outcomes
and statistical analyses
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Chiaravalloti 2013 (Continued)
Other bias Low risk None identified
das Nair 2012
Methods Single-blind RCT, randomisation by off-site independent randomisation centre, com-
puter generated random number sequence
Participants n = 39 with MS
Randomised (A: 17, B: 12, C: 10)
Mean age: 47.2 years
Education years: 14.1 years
Interventions Groups:
A: Restitution - encoding and retrieval strategies, attention retraining
B: Compensation - external memory aids
C: Attention placebo - relaxation techniques
10 weekly sessions, 90 mins each
Outcomes Intention-to-treat analysis used
Non-significant differences between groups on RBMT-E, EMQ, EMAQ, GHQ,
MATBD, and EADL; significant differences in IMAQbetween groups; significant main-
effect on RBMT-E and MATBD over time but across all 3 groups
Notes Analysis used in this review: A + B vs C
RCT: Randomised controlled trial; RBMT-E: Rivermead Behavioural Memory Test-
Extended; EMQ: Everyday Memory Questionnaire; EMAQ: External Memory Aids
Questionnaire; GHQ: General Health Questionnaire; MATBD: Mental Adjustment to
Brain Damage; EADL: Extended Activities of Daily Living; IMAQ: Internal Memory
Aids Questionnaire
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computerised random number generation
by independent agency
Allocation concealment (selection bias) Low risk Allocation was not known by intervention
provider until all 4 participants were allo-
cated to a group
Blinding (performance bias and detection
bias)
All outcomes
Low risk Outcome assessors were blind to the ran-
dom allocation and the intervention partic-
ipants received. Participants were requested
not to disclose any information about in-
tervention at follow-up
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das Nair 2012 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk List-wise deletion utilised and baseline data
were imputed for missing follow-up data
Selective reporting (reporting bias) Low risk All data were analysed and results disclosed
Other bias Low risk None identified
Gich 2015
Methods Randomised, controlled, single-blind pilot study
Participants n = 43 (only 41 analysed), RRMS and SPMS
E: 22 (21 analysed), C: 21 (20 analysed)
Interventions Experimental group received 2x 75-minute sessions per week for 6 months, included
written (crosswords, word searches), manipulative (origami, spatial games) and comput-
erised tasks (workingmemory games, log and reasoning games), additionally participants
completed 5-minute daily cognitive activities at home
Control group received no treatment.
Outcomes BRBNT: significant differences favouring experimental on 10/36 spatial task and word
list generation. No significant differences on list-learning task (selective reminding task)
- used in the meta-analysis
Notes BRBNT: Brief Repeatable Battery of Neuropsychological Tests; RRMS: Relapsing re-
mitting multiple sclerosis; SPMS: Secondary progressive multiple sclerosis
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Participants were randomly assigned to
one of the two arms in a 1:1 ratio. The ran-
domization was stratified to avoid possible
confounding variables, using the level of
cognitive impairment as strata”. No men-
tion of how the random sequence was gen-
erated
Allocation concealment (selection bias) Unclear risk No mention of allocation concealment
Blinding (performance bias and detection
bias)
All outcomes
Low risk Outcome assessors blind to treatment allo-
cation
Incomplete outcome data (attrition bias)
All outcomes
Low risk Analysed only those who completed out-
comes, only 1 withdrew from each group
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Gich 2015 (Continued)
Selective reporting (reporting bias) Low risk None apparent
Other bias Low risk None apparent
Hancock 2015
Methods Blinded, placebo-controlled design, block-stratified randomisation method
Participants n = 40 (n = 30 analysed)
Mean age: 48.8y
Mean education: 15.45y
Interventions Active training group: completed a computerised cognitive training programme that
specifically aimed to improve information-processing speed and working memory. Com-
pleted 30-minute intervals, 6 days per week for 6 weeks
Control group: completed a computerised cognitive training programme that is almost
identical to the active training group, but this programme is not intended to improve
information-processing speed or working memory. This programme employed the same
tasks as the former, but it did not increase in difficulty in order to challenge participants
to improve. Same time intervals and length as active training group
Outcomes Completed immediately after the 6-week training programme.
No significant differences between groups on AVLT, BDI-FS, MSIS, MSQOL
Notes AVLT: Auditory Verbal Learning Test; BDI-FS: Beck Depression Inventory-Fast Screen;
MSIS: Multiple Sclerosis Impact Scale; MSQOL: Multiple Sclerosis Quality of Life
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “A block stratified randomization method
was employed”
Allocation concealment (selection bias) Unclear risk No mention of allocation concealment
Blinding (performance bias and detection
bias)
All outcomes
Low risk Invesigator who conducted assessment was
blind to allocation, as were participants
Incomplete outcome data (attrition bias)
All outcomes
High risk 71 were randomised and 31 “either with-
drew from the study or were lost to follow
up”, however, no statistical differences were
observed for those who completed com-
pared to those who withdrew/lost to fol-
low-up. Analysis on only those who com-
pleted the trial, and were “good adherers”
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Hancock 2015 (Continued)
to intervention (at least 80% sessions at-
tended)
Selective reporting (reporting bias) High risk Analysis only on those who were “good ad-
herers” and completed trial. Not all out-
comes reported in published article (BDI
and MSQOL not reported), unpublished
data (received from author) used in this
meta-analysis
Other bias Low risk None identified
Hanssen 2015
Methods Prospective, randomised controlled design
Participants n = 120, E: 60, C: 60
Inpatients at multidisciplinary rehabilitation centre
Interventions Inpatient cognitive rehabilitation. All participants givenbaseline neuropsychological test-
ing, control offered no feedback. Experimental group offered feedback, used to develop
individualised plan
Mix of individual and group sessions, focused around goal attainment. Sessions included
psychoeducation, learning strategies for “keeping track of appointments and belongings”.
After discharge, those in experimental group had 6 bi-weekly telephone sessions focused
on the goals they had set during the intervention
Outcomes No memory outcomes.
MSIS-29. Significant effect of group at 7 months’ follow-up (experimental less distressed
than control)
Notes MSIS-29: Multiple Sclerosis Impact Scale; Analysis only on those completing outcomes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomization was performed by a lot-
tery controlled by the director of the reha-
bilitation center”
Allocation concealment (selection bias) High risk “Concealment of treatment allocation was
not possible due to the nature of the inter-
vention”
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk No mention of blinding, however self re-
ported questionnaires used as follow-ups
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Hanssen 2015 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Analysis only on those who completed fol-
low-up assessments
Selective reporting (reporting bias) Low risk None apparent
Other bias Low risk None apparent
Hildebrandt 2007
Methods Alternating allocation. Participants informed of intervention or assessment. Outcome
assessor blind
Participants n = 42; RRMS only
Randomised: E: 17, C: 25
Mean age: E: 42 years; C: 36.5 years
Interventions E: Memory and working memory rehab tasks. 30 mins/day, 5 days/week, for 6 weeks
C: Assessments only
Outcomes Intention-to-treat analysis used
Non-significant results of CVLT - Short Delay Free/Cued Recall or CVLT - Long Delay
Cued Recall
Significant differences on CVLT long delay free recall
Non-significant results of BDI, SF-12, EDSS
Notes E: Experimental; C: Control; RRMS: Relapsing remitting multiple sclerosis; CVLT:
California Verbal Learning Test; BDI: Beck Depression Inventory; SF-12: 12-Item Short
Form Health Survey; EDSS: Expanded Disability Status Scale
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk “Before the patients’ assessment, randomi-
sation was done by alternating between in-
tervention and control group”
Allocation concealment (selection bias) Unclear risk “Assignment and enrolment was done by
randomisation according to groups before
the patients were contacted”. Participants
were informed of whether they would re-
ceive intervention, or assessment only
Blinding (performance bias and detection
bias)
All outcomes
Low risk Participants not blinded, healthcare
providers not blinded.
Outcome assessors reportedly blinded:
“done by colleagues, whowere not involved
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Hildebrandt 2007 (Continued)
in the study”
Incomplete outcome data (attrition bias)
All outcomes
Low risk No incomplete data
Selective reporting (reporting bias) Low risk No selective reporting apparent
Other bias Low risk None identified
Jønsson 1993
Methods Closed-envelope randomisation
Participants n = 40 (E: 20; C: 20) hospital inpatients; (16 + 16 completed)
Mean age: 44.5 years (SD: 8.3)
Education: 11.5 years (SD: 2.5)
Gender: 19F, 21M
Groups comparable on all variables, except visuospatial memory and visual perception
(more impaired in E group)
Mild-moderate cognitive impairments
Interventions Individual treatment
1-1.5h, 3 times/week; mean total hrs: 17.2 (5.1)
E: compensation (internal and external memory aids), substitution, direct training (puz-
zles, etc.) + neuropsychotherapy
C: attention placebo: discussion and games
Outcomes Intention-to-treat analysis not used
Follow-up 1: E > C on visual perception (but could be due to regression towards the
mean and ceiling effects) and BDI
Follow-up 2: E > C on visuospatial memory and BDI (C group became more depressed)
Notes E: Experimental; C: Control; SD: Standard deviation; BDI: Beck Depression Inventory
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “Randomly recruited”
Allocation concealment (selection bias) Low risk Closed-envelope system
Blinding (performance bias and detection
bias)
All outcomes
Unclear risk “Patients were told there were 2 treatments, but not
which was better”... and ..
“Healthcare providers were not told of patients’ allo-
cation, but a few words would have given it away” ...
and ..
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Jønsson 1993 (Continued)
“At follow up we were in principle blinded to what
kind of treatment patients had been given”, but pa-
tient report/talk could have broken blind
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not stated
Selective reporting (reporting bias) Low risk No selective reporting apparent
Other bias Low risk None identified
Lincoln 2002
Methods Single-blind RCT; independent phone randomisation
Computer generated numbers
Participants n = 240
Randomised (A: 82; B: 79; C: 79)
Completed (A: 77; B: 71; C: 73)
Median age: 40 to 43 years
Age left education: 16 years
Groups comparable on baseline variables
Interventions Individual treatment
A: only baseline assessment with no feedback
B: detailed cognitive assessment with feedback
C: detailed cognitive assessment + feedback + internal and external memory aids
Outcomes Intention-to-treat analysis used
No significant differences between 3 groups on any measures at follow-up 1 or 2 for
patient and relative data, except QoL (Questions 53 and 54 of the MSQOL-54) at
follow-up 2
Notes For this review A vs C compared; RCT: Randomised controlled trial; QoL: Quality of
life
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “telephoning an independent department
who had a computer generated allocation
list”
Allocation concealment (selection bias) Low risk See above
Blinding (performance bias and detection
bias)
Low risk “An independent assessor, who was un-
aware of the group allocation, assessed the
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Lincoln 2002 (Continued)
All outcomes outcome at 4 and 8 months after randomi-
sation”
Incomplete outcome data (attrition bias)
All outcomes
Low risk Analysis was just on those who completed
the outcome assessments, however it in-
cluded those who did not get the interven-
tion as planned
Selective reporting (reporting bias) Low risk No selective reporting apparent
Other bias Low risk None identified
Mendozzi 1998
Methods Single-blind, quasi-RCT
Participants n = 30 randomly allocated to groups, n = 30 matched on age, gender, and education
Interventions Computerised treatment
A: Specific cognitive retraining
B: Non-specific cognitive retraining
C: Control group
15 bi-weekly sessions, 45 mins
Outcomes Intention-to-treat analysis not used
Specific group improved on 7 outcome measures, non-specific on 1 measure
Notes For this review A vs C compared, because B was not considered cognitive rehabilitation;
RCT: Randomised controlled trial
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Only half the sample randomised, with no stated generation
method
Allocation concealment (selection bias) Unclear risk “Assignment by principal investigator, who was not involved
in the CR or cognitive testing and scoring”
Blinding (performance bias and detection
bias)
All outcomes
Low risk Single blinding: “the tests were always administered and
scored by the same investigator who was not involved in the
clinical work and was unaware of the treatment assignments”
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Participant data replaced mid-trial if dropped out
Selective reporting (reporting bias) Low risk No selective reporting apparent
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Mendozzi 1998 (Continued)
Other bias Unclear risk 1 participant in the specific cognitive retraining group dis-
continued retraining and was replaced by a new entry
Pusswald 2014
Methods Alternating allocation
Participants n = 40 (Intervention: 20, Control: 20)
Both groups comparable on clinical and sociodemographic baseline characteristics
Interventions Cognitive functional training, computer-based home training of divided attention, car-
ried out 3/week for 30 minutes for 5 weeks alongside weekly 90-minute sessions in
groups focusing on cognitive rehabilitation techniques and approaches, and included
memory retraining
Control group received no specific training.
Outcomes Significant within-group effect on objective memory for intervention group when com-
paring before training to after training
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Alternating allocation
Allocation concealment (selection bias) Unclear risk No mention of allocation concealment
Blinding (performance bias and detection
bias)
All outcomes
High risk Outcome assessor not blind
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk No mention of incomplete data
Selective reporting (reporting bias) Low risk No selective reporting apparent
Other bias Low risk None identified
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Solari 2004
Methods Independent randomisation; computer-generated, site-stratified schedule; double-blind
Participants n = 82
Randomised: E: 42; C: 40
Analysed: E: 40; C: 37
Age: E: 46.2 years (SD: 9.2); C: 41.2 years (SD: 10.6)
Education: E: 21 C: 20 high school+
Interventions Individual treatment
45 min, 2 per week, 8 weeks
Computerised programmes
E: memory and attention retraining
C: visuoconstruction and visuomotor co-ordination
Outcomes Intention-to-treat analysis used
No significant differences between groups on any measures at follow-up 1 or 2, when
Bonferroni adjustments made
Notes E: Experimental; C: Control; SD: Standard deviation
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “were assigned to one of the two inter-
ventions by an independent randomisa-
tion unit, using a computer-generated, site-
stratified, randomisation schedule.”
Allocation concealment (selection bias) Low risk “were assigned to one of the two inter-
ventions by an independent randomisa-
tion unit, using a computer-generated, site-
stratified, randomisation schedule.”
Blinding (performance bias and detection
bias)
All outcomes
Low risk Participants, healthcare providers, and out-
come assessors all blinded
Outcome assessor asked to guess partici-
pant group
Incomplete outcome data (attrition bias)
All outcomes
Low risk “Missing values were imputed according
to the ’last observation carried forward’
method”
Selective reporting (reporting bias) Low risk No selective reporting apparent
Other bias Low risk None identified
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Stuifbergen 2012
Methods Single-blind randomised controlled trial
Participants n = 61 (Intervention: 34, Control: 27)
Age range 24 to 60 years, mean: 47.95
Length of time since diagnosis range 1 to 29 years, mean: 12.2
Interventions Group based; MAPSS-MS (Memory, Attention, and Problem Solving Skills for People
with Multiple Sclerosis)
8 weekly, 2-hour group sessions focused on building efficacy for use of compensatory
strategies, and use of a computer-assisted training programme. Home-based practice
using the computer program
Outcomes Significant difference between groups on CVLT-total (medium effect size) and Strategy
subscale of the Multifactorial Memory Questionnaire (large effect size), E > C
Both groups improved over time on neuropsychological testing, ADLs, and use of com-
pensatory strategies
Notes CVLT-total: California Verbal Learning Test; ADL: Activities of daily living; E: Experi-
mental, C: Control
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk “Prior to the initiation of data collection, the
data analysts for the project generated a ran-
dom number sequence for randomization to
intervention and control”
Allocation concealment (selection bias) Low risk Each allocation placed in sealed envelope
prior to study start and opened by project
director when participant randomised, to let
them know their allocation
Blinding (performance bias and detection
bias)
All outcomes
Low risk “The staff members conducting neuropsy-
chological assessments were blinded to par-
ticipants’ group assignment”. States that
those involved in intervention were not in-
volved in collecting, entering, or analysing
data
Incomplete outcome data (attrition bias)
All outcomes
Low risk Intention to treat; participant analysed if
completed baseline and attended at least
1 class. Missing values replaced using last
observation carried forward. If participant
missed time point 2, but completed 1 and 3,
then 2 was an average of 1 and 3
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Stuifbergen 2012 (Continued)
Selective reporting (reporting bias) Low risk No selective reporting apparent, full analyses
available
Other bias Low risk None identified
Tesar 2005
Methods Simple random sampling with independent allocation
Participants n = 19 (E: 10; C: 9)
Mild-moderate cognitive deficits
Groups comparable on baseline variables
Interventions Group treatment
E: 12 1-hour sessions in 4 weeks; neuropsychological training programme; computer-
based direct functional training internal and external memory
C: rehabilitation only
Outcomes Intention-to-treat analysis not used
Significant differences between groups seen only on CKV and HAWIE-R (but practice
effects as no parallel forms used?)
No other significant differences on other measures
Based on feedback interview, authors conclude treatment effectiveness
Notes E: Experimental; C: Control; CKV: Computer-aided card-sorting procedure; HAWIE-
R: Hamburg Wechsler Intelligence Test-Revised
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk “simple random sampling”
Allocation concealment (selection bias) Low risk “Allocation to the two study groups (treated
and control group) was done by a person
who worked in an out-patient MS facility
and who was not involved in the study”
Blinding (performance bias and detection
bias)
All outcomes
High risk “The participants were aware of each in-
tervention” but no indication of assessor
blinding
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Nomention of how drop-out data handled
Selective reporting (reporting bias) Low risk No selective reporting apparent
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Tesar 2005 (Continued)
Other bias Low risk None identified
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Aisen 1994 Non-RCT with a mixed aetiology group, non-memory
Akhtar 2006 Not MS
Aldrich 1995 Not just MS, non-RCT
Allen 1998 Non-RCT, no control
Amato 2014 Focus on attention, not memory
Bonavita 2015 No memory focus, active control
Brenk 2008 Non-RCT, allocated participants by demographics
Brissart 2010 Non-RCT, no control group
Brissart 2013 Non-RCT
Cabrera-Gomez 2010 No memory focus, non-RCT
Canellopoulou 1998 Not memory rehabilitation, not MS control group
Chiaravalloti 2003 Non-RCT, healthy controls
Chiaravalloti 2012 Same sample as Chiaravalloti 2013
Dobryakova 2014 Same sample as Chiaravalloti 2013
Ernst 2013 Non-RCT, healthy controls
Flavia 2010 Not memory rehabilitation
Goreover 2011 Not memory rehabilitation
Leavitt 2012 Subgroup analysis of Chiaravalloti 2013
Loewenstein 2004 Not MS: Alzheimer’s disease
44Memory rehabilitation for people with multiple sclerosis (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Martin 2014 Subgroup analysis of das Nair 2012
Mattioli 2012 Not memory specific
Moore 2008 No rehabilitation, as intervention only involved 1 session of 1 hour
Mäntynen 2014 Not memory specific
Nurova 2014 Conference poster presentation, no full text available
Rodgers 1996 Non-RCT
Rosti-Otajärvi 2013a Not memory specific
Rosti-Otajärvi 2013b Not memory specific
Shatil 2010 Non-RCT
Thaut 2014 No cognitive rehabilitation
Thomas 2006 Non-RCT: systematic review
van der Putten 1999 Stroke and MS patients, non-RCT, non-memory
Vogt 2009 No MS control group, only healthy controls
Wilson 2001 They do not distinguish results for participants withMS from those for participants with acquired progressive
brain injury; no MS control group
MS: multiple sclerosis
RCT: randomised controlled trial
Characteristics of ongoing studies [ordered by study ID]
ISRCTN09697576
Trial name or title Cognitive Rehabilitation for Attention and Memory for people with Multiple Sclerosis (CRAMMS): a prag-
matic randomised controlled trial
Methods Single-blind, randomised controlled trial
Cluster randomisation where participants will be individually randomised (6:5) to allow for clustering in the
intervention arm, stratified by recruitment site and minimised byMS type (relapsing remitting or progressive)
and gender. The randomisation will take place once 9 to 11 individuals have consented who are able to attend
the same therapy group (location, day of the week and time of day) should they be randomised to receive it
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ISRCTN09697576 (Continued)
Participants Planned sample size: 400
Age: 18 to 70
Inclusion criteria:
1. Are 18 or over and under 70 years of age. The lower age limit is because MS is usually diagnosed in
adulthood, and treatment strategies tend to be different for children. People aged 70 and over may start to
encounter age-related cognitive problems, which may confound the effects of cognitive problem due to MS.
Also, most tests are standardised on this adult age group.
2. Have relapsing or progressive MS, diagnosed at least 3 months prior to the baseline assessment contact
with the study team, to allow for adjustment to diagnosis. Report having cognitive problems as determined
by a cut-off score of > 27 on the patient version of the Multiple Sclerosis Neuropsychological Screening
Questionnaire (MSNQ). This cut-off is based on previous research and is 2 standard deviations below the
mean for healthy participant.
3. Have cognitive deficits, defined as performance below the 25th percentile on the Brief Repeatable
Battery of Neuropsychological Tests (BRBN).
4. Are able to travel to one of the centres and attend group sessions.
5. Are able to speak English sufficiently to complete the cognitive assessments and take part in group
sessions.
6. Give informed consent.
Exclusion criteria:
1. Vision or hearing problems, such that they are unable to complete the cognitive assessments, judged by
assessor.
2. Have concurrent severe medical or psychiatric conditions that would prevent person from engaging in
treatment, if allocated.
3. Are involved in other psychological intervention trial.
Interventions The intervention is cognitive rehabilitation, offered in addition to usual clinical care. The rehabilitation is
delivered to groups of 4 to 6 participants for 10 weekly sessions. The programme will be tailored to each
person’s cognitive status, while maintaining a systematic approach to attention and memory by following a
treatment manual.
The control group participants will receive their usual clinical care, which may include information on
cognitive problems but not cognitive rehabilitation
Outcomes Primary outcome measures
Psychological impact of MS; time point(s): 12 months
Secondary outcome measures
1. Memory problems in everyday life; time point(s): 6 and 12 months
2. Mood; time point(s): 6 and 12 months
3. Fatigue; time point(s): 6 and 12 months
4. Carer strain; time point(s): 6 and 12 months
5. Quality of life; time point(s): 6 and 12 months
6. Attention and memory abilities; time point(s): 6 and 12 months
7. Physical impact of MS; time point(s): 6 and 12 months
8. Cost-effectiveness; time point(s): 6 and 12 months
9. Employment status; time point(s): 6 and 12 months
10. Number of reported relapses in the previous 6 months; time point(s): 6 and 12 months
11. Disability; time point(s): 6 and 12 months
Starting date September 2014
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ISRCTN09697576 (Continued)
Contact information cramms@nottingham.ac.uk
Notes
ISRCTN54901925
Trial name or title A randomised study of cognitive rehabilitation in multiple sclerosis
Methods Randomised controlled trial
Participants Planned sample size: 50
Adult
Participant inclusion criteria:
1. Diagnosis of MS by consultant neurologist to best current criteria.
2. Able and willing to give informed consent.
3. Cognitive impairment defined by scoring below 5th percentile on 1 or more of BICAMS scales
(Langdon 2012) as identified at the clinic.
4. Willing to commit to 3x 45-minute computer training sessions for 6 weeks.
5. Home PC fulfilling experimental spec.
6. Willing to attend total of 3 MRI scans at the University of Sussex MRI scanner.
7. Age between 18 and 70.
Participant exclusion criteria:
1. Significant change in medications in last 4 weeks.
2. Relapse recovery within last 4 weeks.
3. Sensorimotor dysfunction likely to interfere with PC interface.
4. Significant psychiatric history/condition.
5. Significant medical condition (other than MS), personal or social circumstances likely to influence
cognition or study participation.
6. Women who are pregnant.
Interventions Participants will be randomised to undergo either cognitive rehabilitation with RehaCom Software (3x 45-
minute training sessions per week for 6 weeks) or be placed in the placebo arm to spend the same amount of
time in the control condition (natural history DVDs). During this period, they will be expected to undertake
3x 45-minute computer training sessions per week for the 6-week period. There will also be an MRI brain
scan at baseline prior to undertaking the training. Following completion of the 6-week training period, both
the full cognitive assessments and MRI scanning will be repeated immediately following the training period
and again at approximately 3 to 6 months
Outcomes Primary outcome measures
1. Objective cognitive performance: BICAMS (a 15-minute screening tool).
2. Quality of life:
i) EQ-5D, a generic health-related quality of life scale (EuroQoL Group 1990)
ii) Functional Assessment of MS (FAMS), an MS-specific quality-of-life scale (Cella 1996)
Secondary outcome measures
MRI: The data will be acquired on the 1.5T Siemens machine. The following analyses will be completed:
1. Voxel-based morphometry
2. Tensor-based morphometry
3. Cortical thickness
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ISRCTN54901925 (Continued)
4. Lesion load
5. Resting state analysis (default mode network)
6. Diffusion tensor imaging analysis
Starting date November 2013
Contact information Dr Waqar Rashid
Department of Neurology
Royal Sussex County Hospital
Eastern Road
Brighton
BN25BE
Notes
BICAMS: Brief International Cognitive Assessment for Multiple Sclerosis, MRI: Magnetic resonance imaging
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D A T A A N D A N A L Y S E S
Comparison 1. Subjective memory measures
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Immediate 5 314 Std. Mean Difference (IV, Random, 95% CI) 0.04 [-0.19, 0.27]
2 Long term 5 305 Std. Mean Difference (IV, Random, 95% CI) 0.04 [-0.19, 0.27]
Comparison 2. Objective memory measures
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Immediate 11 503 Std. Mean Difference (IV, Random, 95% CI) 0.23 [0.05, 0.41]
2 Long term 6 302 Std. Mean Difference (IV, Random, 95% CI) 0.26 [0.03, 0.49]
Comparison 3. Mood
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Immediate 9 490 Std. Mean Difference (IV, Random, 95% CI) 0.02 [-0.16, 0.20]
2 Long term 7 413 Std. Mean Difference (IV, Random, 95% CI) -0.01 [-0.21, 0.20]
Comparison 4. ADL
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Immediate 2 186 Std. Mean Difference (IV, Random, 95% CI) -0.13 [-0.60, 0.33]
2 Long term 2 186 Std. Mean Difference (IV, Random, 95% CI) -0.33 [-0.63, -0.03]
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Comparison 5. Quality of life
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Immediate 7 485 Std. Mean Difference (IV, Random, 95% CI) 0.23 [0.05, 0.41]
2 Long term 5 406 Std. Mean Difference (IV, Random, 95% CI) 0.16 [-0.03, 0.36]
Analysis 1.1. Comparison 1 Subjective memory measures, Outcome 1 Immediate.
Review: Memory rehabilitation for people with multiple sclerosis
Comparison: 1 Subjective memory measures
Outcome: 1 Immediate
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Carr 2014 17 -21.7 (13.1) 21 -25.8 (19.9) 12.3 % 0.23 [ -0.41, 0.88 ]
Chiaravalloti 2005 13 77.67 (26.69) 13 81.38 (22.19) 8.6 % -0.15 [ -0.92, 0.62 ]
das Nair 2012 29 -42.48 (22.44) 10 -41.1 (18.95) 9.8 % -0.06 [ -0.78, 0.66 ]
Lincoln 2002 74 -23.32 (20.28) 76 -26.11 (24.02) 49.5 % 0.12 [ -0.20, 0.45 ]
Stuifbergen 2012 34 -29.68 (10.74) 27 -27.92 (11.11) 19.8 % -0.16 [ -0.67, 0.35 ]
Total (95% CI) 167 147 100.0 % 0.04 [ -0.19, 0.27 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 1.52, df = 4 (P = 0.82); I2 =0.0%
Test for overall effect: Z = 0.35 (P = 0.73)
Test for subgroup differences: Not applicable
-0.5 -0.25 0 0.25 0.5
Control Experimental
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Analysis 1.2. Comparison 1 Subjective memory measures, Outcome 2 Long term.
Review: Memory rehabilitation for people with multiple sclerosis
Comparison: 1 Subjective memory measures
Outcome: 2 Long term
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Carr 2014 15 -17.3 (11.2) 16 -26.9 (19.3) 10.0 % 0.59 [ -0.13, 1.31 ]
Chiaravalloti 2005 13 79 (29.31) 13 83.92 (22.53) 8.8 % -0.18 [ -0.95, 0.59 ]
das Nair 2012 27 -40.44 (22.55) 10 -45 (20.64) 9.9 % 0.20 [ -0.53, 0.93 ]
Lincoln 2002 73 -22.37 (23.62) 77 -23.3 (21.86) 50.9 % 0.04 [ -0.28, 0.36 ]
Stuifbergen 2012 34 -28.41 (11.13) 27 -26.15 (11.56) 20.4 % -0.20 [ -0.70, 0.31 ]
Total (95% CI) 162 143 100.0 % 0.04 [ -0.19, 0.27 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 3.56, df = 4 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 0.37 (P = 0.71)
Test for subgroup differences: Not applicable
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Analysis 2.1. Comparison 2 Objective memory measures, Outcome 1 Immediate.
Review: Memory rehabilitation for people with multiple sclerosis
Comparison: 2 Objective memory measures
Outcome: 1 Immediate
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Chiaravalloti 2005 14 26.57 (3.69) 14 26.29 (2.89) 5.8 % 0.08 [ -0.66, 0.82 ]
Chiaravalloti 2013 45 50.13 (11.99) 41 45.24 (13.44) 17.4 % 0.38 [ -0.05, 0.81 ]
das Nair 2012 29 98.57 (17.18) 10 87.6 (24.73) 6.0 % 0.56 [ -0.17, 1.29 ]
Gich 2015 21 51.3 (8.8) 20 52.3 (7.3) 8.5 % -0.12 [ -0.73, 0.49 ]
Hancock 2015 15 54.75 (8.7) 15 46.79 (13.02) 5.8 % 0.70 [ -0.04, 1.44 ]
Hildebrandt 2007 17 13.18 (3.05) 25 11.32 (3.45) 8.0 % 0.55 [ -0.07, 1.18 ]
Mendozzi 1998 20 -57.7 (5.8) 20 -59.7 (5.6) 8.1 % 0.34 [ -0.28, 0.97 ]
Pusswald 2014 20 14.4 (3.3) 20 14.38 (3.5) 8.3 % 0.01 [ -0.61, 0.63 ]
Solari 2004 40 5.81 (3.01) 37 6.05 (3.84) 15.9 % -0.07 [ -0.52, 0.38 ]
Stuifbergen 2012 34 52.2 (12.3) 27 50.2 (12.1) 12.4 % 0.16 [ -0.34, 0.67 ]
Tesar 2005 10 52 (8.2) 9 48.2 (13.1) 3.8 % 0.34 [ -0.57, 1.25 ]
Total (95% CI) 265 238 100.0 % 0.23 [ 0.05, 0.41 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 7.70, df = 10 (P = 0.66); I2 =0.0%
Test for overall effect: Z = 2.53 (P = 0.012)
Test for subgroup differences: Not applicable
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Analysis 2.2. Comparison 2 Objective memory measures, Outcome 2 Long term.
Review: Memory rehabilitation for people with multiple sclerosis
Comparison: 2 Objective memory measures
Outcome: 2 Long term
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Chiaravalloti 2005 14 27.07 (5.15) 14 27.64 (3.61) 9.7 % -0.12 [ -0.87, 0.62 ]
Chiaravalloti 2013 40 42.79 (15.75) 38 35.94 (16.47) 26.5 % 0.42 [ -0.03, 0.87 ]
das Nair 2012 29 102.24 (15.62) 10 92.35 (21.35) 10.0 % 0.56 [ -0.17, 1.29 ]
Solari 2004 40 6.08 (2.87) 37 6 (3.08) 26.7 % 0.03 [ -0.42, 0.47 ]
Stuifbergen 2012 34 58.4 (13.6) 27 53.8 (14.3) 20.7 % 0.33 [ -0.18, 0.84 ]
Tesar 2005 10 56.9 (13.1) 9 50.4 (13.6) 6.4 % 0.47 [ -0.45, 1.38 ]
Total (95% CI) 167 135 100.0 % 0.26 [ 0.03, 0.49 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 3.50, df = 5 (P = 0.62); I2 =0.0%
Test for overall effect: Z = 2.21 (P = 0.027)
Test for subgroup differences: Not applicable
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Analysis 3.1. Comparison 3 Mood, Outcome 1 Immediate.
Review: Memory rehabilitation for people with multiple sclerosis
Comparison: 3 Mood
Outcome: 1 Immediate
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Carr 2014 16 -23.7 (10.9) 21 -22.7 (9.9) 7.6 % -0.09 [ -0.75, 0.56 ]
Chiaravalloti 2005 14 -6.21 (6.2) 14 -8.36 (6.28) 5.8 % 0.33 [ -0.41, 1.08 ]
Chiaravalloti 2013 45 -55.05 (15.7) 41 -56.39 (12.92) 18.0 % 0.09 [ -0.33, 0.52 ]
das Nair 2012 29 -14.28 (2.79) 10 -15.7 (7.6) 6.2 % 0.31 [ -0.41, 1.03 ]
Hancock 2015 15 -3.63 (2.58) 11 -3.09 (2.39) 5.3 % -0.21 [ -0.99, 0.57 ]
Hildebrandt 2007 17 -10.3 (8.5) 25 -11 (7.9) 8.5 % 0.08 [ -0.53, 0.70 ]
Lincoln 2002 73 -25.34 (13.27) 76 -25.24 (14.6) 31.3 % -0.01 [ -0.33, 0.31 ]
Solari 2004 35 -28.5 (13.1) 29 -27.6 (8.9) 13.3 % -0.08 [ -0.57, 0.41 ]
Tesar 2005 10 -8.6 (4.1) 9 -7.7 (3.2) 3.9 % -0.23 [ -1.14, 0.67 ]
Total (95% CI) 254 236 100.0 % 0.02 [ -0.16, 0.20 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 2.39, df = 8 (P = 0.97); I2 =0.0%
Test for overall effect: Z = 0.24 (P = 0.81)
Test for subgroup differences: Not applicable
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Analysis 3.2. Comparison 3 Mood, Outcome 2 Long term.
Review: Memory rehabilitation for people with multiple sclerosis
Comparison: 3 Mood
Outcome: 2 Long term
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Carr 2014 17 -18.4 (7) 16 -25.3 (10.9) 8.1 % 0.74 [ 0.03, 1.45 ]
Chiaravalloti 2005 14 -6.79 (8.15) 14 -7.29 (6.8) 7.4 % 0.06 [ -0.68, 0.81 ]
Chiaravalloti 2013 40 -54.44 (15.62) 38 -56.48 (11.46) 19.6 % 0.15 [ -0.30, 0.59 ]
das Nair 2012 29 -15.93 (8.61) 10 -14.1 (6.14) 7.8 % -0.22 [ -0.94, 0.50 ]
Lincoln 2002 73 -27 (15.7) 77 -24.9 (14.7) 35.2 % -0.14 [ -0.46, 0.18 ]
Solari 2004 34 -28.03 (12.87) 32 -25.84 (8.45) 16.7 % -0.20 [ -0.68, 0.29 ]
Tesar 2005 10 -8.3 (5.8) 9 -8.3 (3.4) 5.1 % 0.0 [ -0.90, 0.90 ]
Total (95% CI) 217 196 100.0 % -0.01 [ -0.21, 0.20 ]
Heterogeneity: Tau2 = 0.00; Chi2 = 6.34, df = 6 (P = 0.39); I2 =5%
Test for overall effect: Z = 0.05 (P = 0.96)
Test for subgroup differences: Not applicable
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Analysis 4.1. Comparison 4 ADL, Outcome 1 Immediate.
Review: Memory rehabilitation for people with multiple sclerosis
Comparison: 4 ADL
Outcome: 1 Immediate
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
das Nair 2012 26 48.54 (10.87) 9 45.56 (14.14) 28.0 % 0.25 [ -0.51, 1.01 ]
Lincoln 2002 74 40.87 (18.39) 77 45.82 (16.49) 72.0 % -0.28 [ -0.60, 0.04 ]
Total (95% CI) 100 86 100.0 % -0.13 [ -0.60, 0.33 ]
Heterogeneity: Tau2 = 0.05; Chi2 = 1.59, df = 1 (P = 0.21); I2 =37%
Test for overall effect: Z = 0.56 (P = 0.57)
Test for subgroup differences: Not applicable
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Analysis 4.2. Comparison 4 ADL, Outcome 2 Long term.
Review: Memory rehabilitation for people with multiple sclerosis
Comparison: 4 ADL
Outcome: 2 Long term
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
das Nair 2012 27 48.52 (11.28) 9 50.89 (12.41) 15.4 % -0.20 [ -0.96, 0.56 ]
Lincoln 2002 73 39.96 (18.18) 77 46.2 (16.93) 84.6 % -0.35 [ -0.68, -0.03 ]
Total (95% CI) 100 86 100.0 % -0.33 [ -0.63, -0.03 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 0.13, df = 1 (P = 0.71); I2 =0.0%
Test for overall effect: Z = 2.18 (P = 0.029)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Control Experimental
56Memory rehabilitation for people with multiple sclerosis (Review)
Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 5.1. Comparison 5 Quality of life, Outcome 1 Immediate.
Review: Memory rehabilitation for people with multiple sclerosis
Comparison: 5 Quality of life
Outcome: 1 Immediate
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Carr 2014 16 -77.2 (30.7) 21 -69 (23.6) 7.6 % -0.30 [ -0.95, 0.36 ]
Chiaravalloti 2013 45 20.91 (14.79) 41 14.59 (5.38) 17.4 % 0.55 [ 0.12, 0.98 ]
Hancock 2015 15 -69.69 (12.37) 11 -73.65 (15.73) 5.3 % 0.28 [ -0.51, 1.06 ]
Hanssen 2015 50 -18.3 (6.7) 50 -20 (7.7) 20.9 % 0.23 [ -0.16, 0.63 ]
Hildebrandt 2007 25 48.5 (13.3) 17 47.8 (9.7) 8.5 % 0.06 [ -0.56, 0.67 ]
Lincoln 2002 64 47.15 (12.81) 72 43.97 (12.63) 28.3 % 0.25 [ -0.09, 0.59 ]
Solari 2004 31 -46.99 (17.38) 27 -49.26 (12.44) 12.1 % 0.15 [ -0.37, 0.66 ]
Total (95% CI) 246 239 100.0 % 0.23 [ 0.05, 0.41 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 5.08, df = 6 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 2.51 (P = 0.012)
Test for subgroup differences: Not applicable
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Analysis 5.2. Comparison 5 Quality of life, Outcome 2 Long term.
Review: Memory rehabilitation for people with multiple sclerosis
Comparison: 5 Quality of life
Outcome: 2 Long term
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Carr 2014 15 -68.3 (28) 16 -74.6 (25.4) 7.6 % 0.23 [ -0.48, 0.94 ]
Chiaravalloti 2013 40 17.17 (6.82) 38 14.48 (6.31) 19.0 % 0.40 [ -0.04, 0.85 ]
Hanssen 2015 53 -18.3 (7.2) 48 -20.5 (8) 24.8 % 0.29 [ -0.10, 0.68 ]
Lincoln 2002 66 45.42 (11.94) 70 46.52 (13.19) 33.8 % -0.09 [ -0.42, 0.25 ]
Solari 2004 29 -48.57 (17.22) 31 -51.18 (13.06) 14.8 % 0.17 [ -0.34, 0.68 ]
Total (95% CI) 203 203 100.0 % 0.16 [ -0.03, 0.36 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 3.66, df = 4 (P = 0.45); I2 =0.0%
Test for overall effect: Z = 1.62 (P = 0.11)
Test for subgroup differences: Not applicable
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A D D I T I O N A L T A B L E S
Table 1. Sensitivity analysis
Outcome No. of studies No. of participants Effect size
SMD (95% CI)
Heterogeneity (I2) Test for overall effect
Subjective memory
- immediate
4 E = 154
C = 134
0.06 [-0.18, 0.29] 0% Z = 0.48 (P = 0.63)
Subjective memory
- long term
4 E = 149
C = 130
0.07 [-0.18, 0.32] 6% Z = 0.54 (P = 0.59)
Objective memory -
immediate
3 E = 103
C = 74
0.13 [-0.19, 0.44] 4% Z = 0.79 (P = 0.43)
Objective memory -
long term
3 E = 103
C = 74
0.23 [-0.08, 0.53] 0% Z = 1.47 (P = 0.14)
Mood - immediate 4 E = 153
C = 136
-0.00 [-0.24, 0.23] 0% Z = 0.01 (P = 0.99)
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Table 1. Sensitivity analysis (Continued)
Mood - delayed 4 E = 153
C = 135
-0.02 [-0.37, 0.34] 47% Z = 0.08 (P = 0.93)
Quality of life - im-
mediate
3 E = 111
C = 120
0.13 [-0.14, 0.40] 6% Z = 0.94 (P = 0.34)
Quality of life - long
term
3 E = 110
C = 117
0.02 [-0.24, 0.28] 0% Z = 0.18 (P = 0.86)
E: Experimental, C: Control, SMD: Standardised mean difference
A P P E N D I C E S
Appendix 1. Keywords
{attention\*} OR {cognition} OR {cognition disorder\*} OR {cognitive} OR {concentration} OR {distract\*} OR {alert\*} AND {train-
ing} OR {retraining} OR {therap\*} OR {rehabilitation} OR {treatment\*} OR {therapeutic\*} OR {computer assisted therap\*} OR
{computer\*} OR {neuropsychological test\*} OR {neurorehabilitation} OR {neuropsychological rehabilitation} OR {rehabilitation}
OR {cognition} OR {neurological system and disorders} OR {memory} OR {cognitive retraining}
WH A T ’ S N E W
Last assessed as up-to-date: 2 June 2015.
Date Event Description
7 November 2015 New search has been performed Update search completed 2 June 2015. The review now
includes 15 trials
7 November 2015 Amended The review team has been amended
7 November 2015 New citation required and conclusions have changed 7 studies have been added. Conclusion changed. In this
version of the review, the quality of the evidence from
the included studies was assessed using GRADE ap-
proach and a ’Summary of findings’ table was added
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C O N T R I B U T I O N S O F A U T H O R S
RdN and NBL conceptualised the protocol for the review. KJM ran the searches and collected the studies. KJM and RdN reviewed the
studies, which were verified by NBL. RdN and KJM wrote the review with input from NBL.
D E C L A R A T I O N S O F I N T E R E S T
RdN and NBL have conducted memory rehabilitation studies in MS that have been included in this review. KJM has nothing to
declare.
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We did not perform subgroup analyses because data were not available.
I N D E X T E R M S
Medical Subject Headings (MeSH)
Audiovisual Aids; Memory Disorders [etiology; ∗rehabilitation]; Multiple Sclerosis [∗complications]; Randomized Controlled Trials as
Topic; Therapy, Computer-Assisted [methods]
MeSH check words
Humans
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